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1. INTRODUCTION 
1.1 Overview of human spermatogenesis 
Human spermatogenesis represents a complex and multi-stage 
differentiation process starting with spermatogonia, which continuously divide 
and differentiate finally ending up in the permanent production of fertile sperm 
(Figure 1). Starting at puberty, spermatogenesis occurs at the surface of the 
somatic Sertoli cells within the seminiferous tubules of the testes and can be 
divided into three major periods: pre-meiotic (or mitotic), meiotic and 
post-meiotic (or spermiogenesis) (Krawetz 2005; Allais-Bonnet & Pailhoux 
2014). Diploid spermatogonia located at the basal lamina undergo mitotic 
divisions and finally differentiate into diploid primary spermatocytes, which 
enter meiosis and generate haploid secondary spermatocytes (1st meiotic 
division) and haploid round spermatids (2nd meiotic division). The latter will not 
divide any more, but differentiate into elongated spermatids and within the 
epididymis into motile and mature spermatozoa with the capability to fertilize 
oocytes (Krawetz 2005; Allais-Bonnet & Pailhoux 2014). 
 
Figure 1 Illustration of human spermatogenesis in the seminiferous tubules of the 
testes (Krawetz, 2005).  
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1.2 Epigenetic processes accompanying human spermatogenesis 
In the pre-meiotic period, it is important to safeguard the stem cell 
character during spermatogonial self-renewal, whereas the meiotic and 
post-meiotic periods are crucial for male germ cell haploidization and 
differentiation into fertile spermatozoa. These latter periods are known to be 
accompanied by a drastic epigenetic reprogramming including a genome-wide 
DNA methylation erasure of the somatic-like pattern and the re-establishment 
of sex-specific epigenetic pattern by de novo DNA methylation (Hackett et al. 
2013; Molaro et al. 2014; Schagdarsurengin et al. 2016) (Figure 2). During 
spermiogenesis, round spermatids in addition undergo a global remodeling of 
their nuclei, which elongate and get compacted into the unique condensed 
nucleus structure of spermatozoa (Krawetz 2005; Gaucher et al. 2010). A 
drastic epigenetic modification of the chromatin structure takes place during 
this process as well including histone hyper-acetylation, maintenance of DNA 
methylation, chromatin remodeling and histone-to-protamine replacement 
(Moran-Crusio et al. 2011; Carrell 2012; Boissonnas et al. 2013; 
Schagdarsurengin et al. 2016) (Figure 2).  
 
Figure 2 Illustration of epigenetic processes occurring during spermatogenesis 
(Schagdarsurengin et al. 2016). A process of genome-wide DNA demethylation and de 
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novo DNA methylation of paternal-specific imprints occurs in primordial germ cells (PGCs) 
before meiosis I. Then the DNA methylation patterns are maintained until fertilization. In 
post-meiotic maturation, male germ cell nuclei undergo a re-organization and a 
condensation of their genome including maintenance of DNA methylation, histone variants, 
histone hyper-acetylation, transition proteins and a replacement of histones by protamines. 
These epigenetic signatures may contribute to embryo genome activation and early 
embryonic development. 
Accurate epigenetic modifications interact and interdepend on each other 
resulting in the proper generation of haploid spermatozoa with a 
highly-condensed heterochromatin and a paternal-specific epigenome (Wykes 
& Krawetz 2003). Spermatids will undergo a global remodeling of their nuclei 
with chromatin condensation, packing the majority of hyper-methylated 
paternal genome into protamine toroids (Aoki & Carrell 2003; Oliva 2006; 
Carrell 2012; Boissonnas et al. 2013). Therefore, the final differentiation step in 
human spermatogenesis is characterized by a genome-wide chromatin 
hypercondensation through nucleosome-to-protamine exchange. Nevertheless, 
the histone-to-protamine replacement is incomplete in all mammalian species 
analyzed so far, ranging from 1% in mouse (Balhorn et al. 1977) to over 50% in 
some marsupial species (Soon et al. 1997). In men, Samans et al. and 
Hammoud et al. recently reported that 2.9% and 4%, respectively, of the sperm 
genome is packed into remaining nucleosomes using micrococcal nuclease 
digestion and direct high-throughput sequencing of the 146-bp 
mononucleosomal DNA fraction (Hammoud et al. 2009; Samans et al. 2014). 
The incomplete replacement of histones by protamines in human sperm has 
shown the evidence of a residual histone code which is closely associated with 
developmental important genes (Arpanahi et al. 2009; Hammoud et al. 2009). 
Interestingly, the DNA hypomethylated promoters in mature sperm cells 
significantly overlapped with the developmental promoters bound by the 
self-renewal network transcription and signaling factors in human embryonic 
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stem cells (ESC) (Boyer et al. 2005; Hammoud et al. 2009; Carrell & 
Hammoud 2010). In addition, sperm centromere repeats, LINE1 and SINE are 
known to be hypomethylated, and a subset of genes has hypomethylated 
promoters enriched for factors relevant to human preimplantation development 
(Carone et al. 2014; Samans et al. 2014). However, it remains still unclear how 
these promoters escape the wave of de novo DNA methylation and maintain 
the hypomethylated status. Considering the proper network of epigenetic 
modifiers ensures the assembly of an intact and fully functional sperm 
epigenome during spermatogenesis, it provides a possible research direction 
for the elucidation of this phenomenon. 
 
1.3 DNA methylation and demethylation processes in male germ cells 
DNA methylation at the 5’-position of cytosine (5-methylcytosine; 5mC) is 
one of the key epigenetic signatures, which is sometimes called “the fifth 
nucleotide” and plays a crucial role in biological processes, such as 
X-chromosome inactivation, gene expression regulation, retrotransposon 
silencing and genomic imprinting (Jaenisch & Bird 2003; Robertson 2005; Reik 
2007). Emerging evidences have suggested that mature sperm cells contribute 
much more than just the paternal genome to the zygote. The high impact of the 
sperm methylome was emphasized by the finding in zebrafish demonstrating 
that after fertilization the maternal genome is reprogrammed to match the 
paternal methylation, i.e. early embryo methylome is inherited from sperm cells 
but not oocytes (Jiang et al. 2013; Potok et al. 2013). DNA methylation in 
sperm identified as hypomethylated promoters is extensive, and correlated 
with developmental regulators contributing to totipotency, developmental 
decisions and imprinting patterns in embryogenesis (Arpanahi et al. 2009; 
Hammoud et al. 2009). Although sperm has a smaller cellular volume in 
comparison with oocyte carrying limited RNAs and proteins, sperm DNA 
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methylation may play a fundamental role for embryo and progeny on the 
development and inheritance of the epigenetic information. Mature 
spermatozoa exhibit a unique genome-wide CpG-methylation profile 
characterized by a paternal-specific methylation in imprinted genes, by a 
number of sperm-specific hypo- and hypermethylated gene promoters, and by 
global hypomethylation of centromere regions and some classes of 
retrotransposable repetitive DNA elements (Molaro et al. 2011; Krausz et al. 
2012). Certain hypomethylated gene promoters in sperm could be associated 
with RNA- and protein-processing factors acting during pre-implantation 
development (Xue et al. 2013; Samans et al. 2014). On the other hand, 
abnormal DNA methylation levels of imprinted genes have been observed in 
infertile patients with oligozoospermia, azoospermia and idiopathic male 
infertility (Marques et al. 2008; Khazamipour et al. 2009; Poplinski et al. 2010; 
Minor et al. 2011). Aberrant sperm methylome at numerous sequences is 
closely associated with poor semen parameters (Houshdaran et al. 2007). 
Therefore, it could be supposed that sperm DNA methylation and 
demethylation processes are closely linked with male germ cell quality and 
human fertility. 
DNA methylation is catalyzed by DNA methyltransferases (DNMTs) 
including DNMT1, DNMT3A, DNMT3B and the regulatory subunit DNMT3L, 
which have been identified and well characterized during mammalian 
spermatogenesis. DNMT1 ensures DNA methylation maintenance throughout 
spermatogenesis (Bestor 2000; Jaenisch & Bird 2003; Boissonnas et al. 2013). 
DNMT3A and DNMT3B have a catalytic activity for DNA methylation, whereas 
DNMT3L acts as a cofactor of DNMT3A and lacks catalytic activity (Okano et 
al. 1999; Chedin et al. 2002; Gowher et al. 2005). DNMT3A, together with its 
isoform DNMT3L, helps to re-establish DNA methylation during 
spermatogonial differentiation except for the Ras protein-specific guanine 
nucleotide-releasing factor 1 (Rasgrf1) locus, whose imprint is re-established 
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by DNMT3B (Chedin et al. 2002; Kaneda et al. 2004; Kato et al. 2007; 
Marques et al. 2011; Boissonnas et al. 2013). Although 5mC and DNMTs have 
been well characterized, little is known about the mechanisms regulating DNA 
methylation fidelity and preventing the accumulation of aberrant DNA 
methylation during mammalian spermatogenesis. Furthermore, two global 
DNA demethylation waves occur firstly on fertilization in the zygote, and 
secondly in primordial germ cells (PGCs) (Kohli & Zhang 2013). Regarding the 
maternal genome, the mechanisms of DNA demethylation in the zygote and in 
PGCs have been well analyzed and characterized (Dawlaty et al. 2011; Iqbal 
et al. 2011; Tan & Shi 2012; Dawlaty et al. 2013; Hackett et al. 2013; Huang et 
al. 2014). However, the mechanism of global demethylation in the paternal 
pronuclei remains still unclear. 
 
1.4 TET family enzymes and their biological role 
Recent studies have indicated that ten-eleven translocation (TET) proteins 
might act as a potential key to regulate DNA demethylation. Meanwhile, 
5-hydroxymethylcytosine (5hmC) has been recognized as a stable 
intermediate of DNA demethylation with potential regulatory functions in the 
mammalian genome (Branco et al. 2012; Kohli & Zhang 2013; Song & He 
2013). TET proteins, including TET1, TET2 and TET3, belong to the 
2-oxoglutarate (2-OG) and the Fe(II)-dependent dioxygenase superfamily, 
which are a group of enzymes capable of converting 5mC into 5hmC, 
5-formylcytosine (5fC) and 5-carboxycytosine (5caC) through consecutive 
oxidation reactions (Wu & Zhang 2011; Tan & Shi 2012; Williams et al. 2012; 
Kohli & Zhang 2013). TET proteins mainly contain three conserved domains 
including a N-terminal CXXC zinc finger that has a high affinity for clustered 
unmethylated CpG dinucleotides, a cysteine-rich (Cys-rich) region and a 
C-terminal catalytic domain that is typical of 2-OG and Fe(II)-dependent 
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dioxygenases (Tan & Shi 2012; Williams et al. 2012) (Figure 3). A CXXC 
domain can be detected in TET1 and TET3, but not in TET2, having the 
capability to identify target specific genomic regions for their action (Tan & Shi 
2012; Williams et al. 2012; Boissonnas et al. 2013). A Cys-rich region and a 
double-stranded β-helix (DSBH) domain are detectable in all TET proteins, 
which possess a methylcytosine dioxygenase activity to convert 5mC to 5hmC, 
5fC or 5caC with the help of the distinct co-factors, such as adenosine 
triphosphate (ATP) (Williams et al. 2012). 
 
Figure 3 Domain structure and function of human TET family proteins (L Tan et al., 
2012). All human TET proteins have a C-terminal CD domain with an ability of 
methylcytosine dioxygenase activity containing the cysteine (Cys)-rich region and 
double-stranded β-helix (DSBH) fold core oxygenase domain. TET1 and TET3, but not 
TET2, contain a CXXC domain, which mediates their direct DNA-binding ability. 
Several studies indicated that TET proteins might function as DNA 
rate-limiting demethylation regulators, while 5hmC might act as an 
intermediate during DNA demethylation (Branco et al. 2012; Kohli & Zhang 
2013; Song & He 2013). There are multiple pathways and mechanisms 
regulated by the TET protein family in order to convert 5hmC into cytosine, and 
further regulate the dynamics of DNA demethylation and gene transcription 
(Branco et al. 2012; Kohli & Zhang 2013) (Figure 4). Firstly, the deamination 
pathway involves activation-induced deaminase (AID) or APOBEC family 
deaminases to convert 5mC or 5hmC directly to thymidine or 
5-hydroxymethyluracil (5hmU), respectively. Both deamination products could 
be further replaced by unmodified cytosine through the base-excision repair 
(BER) pathway-mediated demethylation (Gu et al. 2011), suggesting one route 
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to achieve TET protein-mediated active DNA demethylation. Secondly, the 
oxidation pathway involves further oxidation products of 5hmC to 5fC and 
5caC by TET proteins, which can be further replaced by an unmodified 
cytosine through the BER pathway with the help of thymine DNA glycosylase 
(TDG) enzyme in vitro and in vivo (He et al. 2011; Ito et al. 2011; Pfaffeneder 
et al. 2011). A dominant mechanism of passive DNA demethylation can be 
observed during preimplantation development. Expression of 5hmC, 5fC and 
5caC is closely associated with the paternal genome in the zygote, which is 
gradually reduced at this developmental stage (Inoue & Zhang 2011). In 
addition, 5fC and 5caC probably can be also catalyzed to become 
deformylated or decarboxylated resulting in the replacement by unmodified 
cytosine (Wu & Zhang 2011; Tan & Shi 2012; Williams et al. 2012; Kohli & 
Zhang 2013). Although current studies have proposed alternative routes 
mediated by TET proteins, active or passive DNA demethylation, the initial 
oxidation of 5mC to 5hmC is a prerequisite for the succeeding demethylation 
processes regulated by the Tet protein family to complete DNA demethylation 
(He et al. 2011; Ito et al. 2011; Maiti & Drohat 2011; Pfaffeneder et al. 2011), 
regardless of how these final steps were mediated (e.g. by deamination, BER 
or TDG action). 
Although forms of TET-mediated DNA epigenetic modifications of 5mC 
into 5hmC in the genome have been studied for just several years, it has been 
demonstrated that the TET protein family is essential in a wide range of 
biological processes, such as the formations of hematologic malignancies and 
carcinoma, the function of stem cells, the development of embryo and the 
regulation of the adult nervous system in brain (Langemeijer et al. 2009; 
Moran-Crusio et al. 2011; Kunimoto et al. 2012; Tan & Shi 2012; Song et al. 
2013; Yang et al. 2013; Zhang et al. 2013; Lee et al. 2014; Ko et al. 2015). 
Meanwhile, 5hmC is also regarded as the “sixth base” and deemed to have a 
potentially crucial role in a branch point in the DNA demethylation pathway 
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(Branco et al. 2012; Kohli & Zhang 2013; Song & He 2013). As our biochemical 
knowledge on TET proteins and its DNA modifying pathways increased, DNA 
demethylation seems to give us a new perspective to re-examine the various 
biological and pathological processes. 
 
Figure 4 The complete network for dynamic modifications of cytosine (C) (Kohli et 
al., 2013). (a) A complete validated pathway for modification of C is indicated. Though 
DNA methyltransferase (DNMT) enzymes, C can be converted into 5mC bases. Then, 
TET protein family (TET1/2/3) can catalyze 5mC oxidation to 5hmC, and further into 5fC 
and 5caC. In the pathway of active modification (AM) followed by passive dilution (PD), 
5hmC will be diluted in a replication-dependent manner and thereby complete DNA 
demethylation. In the pathway of AM followed by active restoration (AR), 5fC and 5caC 
can also be excised by thymine DNA glycosylase (TDG) generating an abasic site as part 
of the base-excision repair (BER) pathway to regenerate unmodified C. (b) The respective 
reactions of DNMT, TET and TDG proteins in the pathway are also shown with all 
reactants indicated. α-KG, α-ketoglutarate; SAM, S-adenosylmethionine; SAH, 
S-adenosylhomocysteine, dCTP, deoxycytidine triphosphate; PPi, pyrophosphate. 
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Regarding the pre-implantation global DNA demethylation of the paternal 
genome in the zygote, the rapid and specific loss of 5mC expression, together 
with the level of demethylation products 5hmC, 5fC and 5caC, has been 
re-examined in light of the discovery of Tet proteins (Figure 5).  
 
Figure 5 Dynamics of 5mC, 5hmC/5fC/5caC and function of Tet3 in pre-implantation 
embryos (Kohli et al., 2013). Maternal DNA is subjected to passive demethylation. 
However, the paternal genome will be demethylated in two steps. After fertilization, Tet3 
converts 5mC into its oxidation products (5hmC/5fC/5caC) in the zygote, and the oxidation 
products are then diluted through a replication-dependent pathway. Subsequently, de 
novo methylation will be re-established by DNMTs from the blastocyst stage. 
Specifically, Tet3 can be detected in the development of pre-implantation 
embryos in order to mediate 5mC expression, with the evidence that loss of 
5mC just coincides with the appearance of 5hmC (Gu et al. 2011; Inoue & 
Zhang 2011; Iqbal et al. 2011; Wossidlo et al. 2011). Interestingly, the other 
two demethylation products 5fC and 5caC can be detected in the paternal 
pronucleus of late zygotic stages as well, whereas the significance of this 
finding is still elusive (Inoue et al. 2011). The maternal DNA is passively 
demethylated, while the paternal genome will be demethylated in two steps 
involving the Tet3 enzyme (Inoue et al. 2011; Smith et al. 2012). Using 
immunostaining and DNA sequencing, it has been revealed that Tet3 will first 
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oxidize 5mC in the paternal genome after fertilization with a dramatic increase 
of 5hmC, 5fC and 5caC, and a simultaneous significant decrease of 5mC 
before the 2-cell stage. Subsequently, the Tet3-generated oxidation products 
are gradually diluted through a replication-dependent process before the 
blastocyst stage. DNA methylation will then be re-established by DNMT 
enzymes with a significant increase of 5mC (Kohli & Zhang 2013). Therefore, 
Tet3 protein seems to be responsible for mediating active demethylation of the 
paternal genome and restore the unmodified cytosine though the passive 
dilution pathway.  
After the establishment of the methylation patterns in the embryo, PGCs 
will go through a second epigenetic reprogramming process, an erasure of 
genome-wide DNA methylation patterns  (Hackett et al. 2012) (Figure 6). 
Studies have revealed that both passive and active pathways contribute to this 
global loss of 5mC into 5hmC. Nevertheless, no dynamic changes of 5fC and 
5caC could be observed (Seisenberger et al. 2012; Hackett et al. 2013; 
Kagiwada et al. 2013; Yamaguchi et al. 2013).  
 
Figure 6 Illustration of the dynamic expressions of 5mC and 5hmC, and the function 
of Tet1 (and Tet2) during the PGCs development (Kohli et al., 2013). DNA 
demethylation in PGCs will go through three stages: loss of bulk DNA methylation in a 
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replication-dependent manner, oxidation of the remaining 5mC to 5hmC by Tet1 (and Tet2) 
protein in epiblast and loss of 5hmC through a replication-dependent passive dilution. 
Specifically, this process of DNA demethylation in PGCs includes three 
stages: (1) loss of bulk DNA methylation in epiblast: a passive dilution of 5mC 
and 5hmC in an apparent replication-dependent (Tet-independent) manner 
(Seisenberger et al. 2012; Hackett et al. 2013; Kagiwada et al. 2013; 
Yamaguchi et al. 2013); (2) oxidation of the remaining 5mC to 5hmC by Tet1 
and Tet2 proteins in epiblast: Tet1 and Tet2 are both expressed during PGCs 
reprogramming, however, only Tet1 is upregulated (Yamaguchi et al. 2012). 
Recent studies reported that loss of Tet1 function did affect locus-specific DNA 
demethylation, particularly at meiotic genes, although the targeted deletion 
and knockdown experiments revealed that Tet1 would not affect global DNA 
demethylation (Dawlaty et al. 2011; Yamaguchi et al. 2012; Vincent et al. 
2013). Additionally, in Tet1 and Tet2 double knockout mice the demethylation 
patterns of some imprinted loci were greatly affected, whereas Tet2 knockout 
alone did not affect PGC phenotype (Li et al. 2011; Quivoron et al. 2011); (3) 
loss of 5hmC through a replication-dependent passive dilution pathway (Kohli 
& Zhang 2013). Therefore, Tet1 and Tet2 proteins might regulate DNA 
demethylation during PGC reprogramming process, however further studies 
are necessary to explore the exact contributions of Tet1 and Tet2 in shaping 
the PGC methylome. 
Substantial amount of 5hmC most likely is derived from enzymatic 
oxidation of 5mC by TET proteins in certain mammalian tissues (Jin et al. 
2010). In general, the 5mC level maintains relatively constant but the 5hmC 
intensity varies significantly among tissues (Globisch et al. 2010; Jin et al. 
2010). 5hmC is most abundant in specific cell types of the brain compared to 
other organs (Kriaucionis & Heintz 2009), and ESCs also have relatively high 
level of 5hmC (Tan & Shi 2012; Shen et al. 2013). For the distribution of 5hmC 
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in human spermatogenesis, Nettersheim and coworkers showed that levels of 
5hmC, 5fC and 5caC were decreasing as spermatogenesis proceeded, while 
5mC levels remained constant suggesting that active DNA demethylation 
becomes downregulated during human spermatogenesis (Nettersheim et al. 
2013). Recently, Gan and colleagues have profiled the global 5hmC 
distribution in eight germ cell types during mouse spermatogenesis and found 
that 5hmC mapped differentially and changed dynamically in genomic regions 
related to the regulation of protein-coding genes, piRNA precursor genes, 
repetitive elements and various transcripts. It indicated that 5hmC in the 
mouse genome was crucial for the differentiation of spermatogenic cells (Gan 
et al. 2013). Moreover, they demonstrated that, for these three Tet members, 
mRNA expressions were well correlated with the total level of 5hmC during 
spermatogenesis, being much greater in diploid cells than in haploid cells (Gan 
et al. 2013).  
 
1.5 Aims of the study 
We hypothesize that enzymes involved in the erasure of DNA methylation 
(TETs), as well as the maintenance and establishment of de novo DNA 
methylation (DNMTs) are crucial for proper assembly of sperm-specific DNA 
methylation patterns, especially at imprinted genes, as well as sperm capability 
and the success of ART treatment.  
Therefore, the five prominent aims of this study are: 
1) to localize mRNA and protein expressions of the TET family members 
during human spermatogenesis by in-situ hybridization (ISH) and 
immunohistochemistry (IHC), respectively, as well as 5hmC using 
immunofluorescence (IF); 
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2) to demonstrate TET1–3 mRNA and protein presences in human 
mature spermatozoa applying reverse transcription-polymerase chain 
reaction (RT-PCR), Western-blot (WB) analysis and 
immunocytochemistry (ICC); 
3) to analyze the possible associations of TET1–3, DNMT1 and DNMT3A 
mRNA levels in mature sperm cells with semen parameters and the 
outcome of ART treatment using reverse transcription followed by 
quantitative PCR (RT-qPCR); 
4) to detect the possible correlations of TET1–3 mRNA expressions 
(RT-qPCR) in ejaculated sperm cells with DNA methylation status at 
TET1–3 CpG-promoters measured by combined bisulfite restriction 
analysis (COBRA) and bisulfite pyrosequencing; 
5) to identify the possible differences of DNA methylation at the imprinted 
gene H19 in mature spermatozoa between fertile donors and subfertile 
patients applying COBRA, and to explore the possible associations of 
aberrant methylation patterns at the imprinted gene H19 with DNA 
methylation governing enzymes using RT-qPCR (TET1–3, DNMT1 
and DNMT3A). 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Human testicular tissue samples 
Human testicular tissues were obtained from patients with obstructive 
azoospermia. Samples were fixed in Bouin’s fixative and embedded in paraffin. 
For histological evaluation, 5µm paraffin sections were stained with 
hematoxylin-eosin, and scored according to Bergmann and Kliesch (Bergmann 
& Kliesch 1998). All testicular tissue specimens exhibiting histological normal 
spermatogenesis were used for IHC, ISH and IF analyses. 
Written informed consent was obtained from each study participant. The 
study was approved by the Ethics Commission of the Medical Faculty of the 
Justus Liebig University Giessen (approval from 15 December 2010 in the 
frame of the Clinical Research Unit KFO181/Period 2 “Mechanisms of male 
factor infertility”, confirmed on 17 December 2014).  
 
2.1.2 Human semen samples 
Human semen samples were obtained from healthy fertile donors at the 
Department of Urology, Pediatric Urology and Andrology Justus Liebig 
University Giessen, and from males of subfertile couples who underwent 
intracytoplasmic sperm injection (ICSI) treatment at the Division of 
Gynecological Endocrinology and Reproductive Medicine, Department of 
Gynecology and Obstetrics, Clinical Centre of the Ludwig Maximilians 
University Munich. In this study, the term “subfertile men” is preferred to the 
term “infertile men” describing a condition when a male is unable to father 
children through natural conception within one year despite regular 
unprotected intercourse, but still has an opportunity to father children via ART 
technology.  
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A total of 164 semen samples were analyzed for TET1 mRNA levels 
(fertile donor, n = 70; subfertile patient, n = 94), 167 semen samples were 
analyzed for TET2–3 mRNA levels (fertile donor, n = 75; subfertile patient, n = 
92; hereof 149 samples overlapped with TET1 analysis) and 96 semen 
samples were analyzed for DNMT1 and DNMT3A mRNA levels (fertile donor, 
n = 48; subfertile couple, n = 48; all samples overlapped with TET1–3 
analyses). The non-overlapping samples were added in order to increase the 
cohorts. All semen specimens were obtained after sexual abstinence for 2-7 
days, which were analyzed according to the recommendations of the 5th WHO 
(World Health Organization. 2010). For research purpose, all swim-up sperm 
cells from ICSI-patients were re-suspended in RNA laterTM (Ambion, 
Heppenheim, Germany) and stored in liquid nitrogen tanks. Semen samples 
from healthy donors were analyzed by peroxidase staining in order to exclude 
the samples with a high number of peroxidase-positive white blood cells 
(WBCs: macrophages, granulocytes and T-lymphocytes). In this study, none of 
the control samples showed leukocytospermia (> 106/ml): in 80% of control 
samples WBCs were not detectable, and 20% specimens contained a 
negligible quantity of WBCs (105/ml) when compared to sperm concentration 
(mean = 67.67 × 106/ml). Ejaculated sperm pellets from healthy donors were 
washed twice in PBS buffer and stored in liquid nitrogen tanks as well 
(Rogenhofer et al. 2013). In order to confirm that the material from the controls 
(non-swim-up sperm cells, n = 63) was suitable in this study, we performed an 
additional experiment: fresh isolated RNAs of swim-up sperm cells from 12 
donors were analyzed for TET1–3, DNMT1 and DNMT3A mRNA levels by 
RT-qPCR. We did not find any differences between “swim-up” and 
“non-swim-up” samples regarding TET1–3, DNMT1 and DNMT3A mRNAs 
(Supplementary information, Table 7) and thus, conclude that the material was 
suitable for this study. 
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The ICSI technology was composed of ovarian stimulation and fresh 
embryo transfer. The procedures of ICSI treatment were performed according 
to our previously described protocol (Rogenhofer et al. 2013). The cut-off for 
fertilization rate (FR) was set at 70% in concordance to the available literatures 
(van Golde et al. 2001; Tournaye et al. 2002; Palermo et al. 2009; Rogenhofer 
et al. 2013). On days 14–16 after ovulation induction, whole blood was 
collected from the females for the measurement of β-hCG to assess an early 
pregnancy outcome. Clinical pregnancy rates (fetal heart action per transferred 
patient; definition of pregnancy by ultrasound) as well as miscarriage rates 
(loss of entire pregnancy ≤ 24 weeks per transferred patient) were also 
assessed in this study. 
All study participants gave their written informed consent. The study was 
approved by the Ethics Commission of the Medical Faculty of the 
Justus-Liebig-University Giessen (approval from 15 December 2010 in the 
frame of the Clinical Research Unit KFO181/Period 2 “Mechanisms of male 
factor infertility”, confirmed on 17 December 2014). 
 
2.1.3 HeLa, PC3 and LNCaP cell lines 
HeLa and PC3 cancer cell lines were used as positive control groups for 
TET1–3 protein expression (Zhang et al. 2014) in order to test the antibodies 
used in IHC, ICC and WB analyses, and LNCaP cancer cell line was used as a 
positive control group to check TET1–2 CpG-promoters methylation by 
COBRA analysis. 
All cell lines were cultured in appropriate culture media (DMEM and RPMI 
supplemented with 10% fetal calf serum and 1% penicillin/streptomycin, Life 
Technologies, Darmstadt, Germany) at 5% CO2 and 37ºC, and introduced for 
immunostainings subsequently. 
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2.2 Methods 
2.2.1 IHC and ICC analyses of TET1–3 proteins 
Mature spermatozoa from fertile donors, formalin-fixed paraffin-embedded 
human testis tissues exhibiting histological normal spermatogenesis and HeLa 
cells as positive control (Zhang et al. 2014) were used for IHC and ICC 
analyses regarding TET1–3 protein staining. 
HeLa cells were seeded in 8-well chamber slides and incubated at 37°C 
overnight. After three times washing with 2% Triton/PBS buffer, cells were 
fixed in 4% paraformaldehyde (PFA) for 10 min. Sperm cells were scratched 
out and dried on slides, incubated in 10 mM dithiothreitol (DTT) reagent for 15 
min for decondensation (optimal time; > 15 min decondensation was critical 
and led to the bursting of the majority of sperm cells), treated with 10 mM 
lithium 3,5-diiodosalicylate/1 mM DTT solution for 2 h, and fixed in 4% PFA for 
1 h. Human testis sections were cut from paraffin-embedded tissue blocks, 
soaked with 10% formaldehyde and fixed on slides. The slides were incubated 
at 42°C overnight and deparaffinized by soaking three times in xylol (each 10 
min), twice in absolute ethanol (each 5 min), twice in 96% ethanol (each 5 min) 
and twice in 70% ethanol (each 5 min). The slides were rehydrated with 
Millipore water, placed in 10% citrate buffer, heated at 96°C for 30 min and 
finally recovered to room temperature (RT). Subsequently, all slides were 
rinsed with 2% Triton/PBS buffer for 5 min and blocked in 3% bovine serum 
albumin (BSA) buffer for 1 h. Primary antibodies were dropped to the slides 
(rabbit anti TET1: 1:400, GeneTex, San Antonio, USA; rabbit anti TET2: 1:400, 
Abcam, Cambridge, UK; rabbit anti TET3: 1:400, Novus, Littleton, USA), and 
the slides were incubated overnight at 4°C. For negative control, 3% BSA was 
used instead of antibodies. After washing with 2% Triton/PBS buffer, slides 
were incubated with the secondary antibody (goat anti rabbit IgG: 1:200, Dako, 
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Glostrup, Denmark) for 1 h at RT, and rinsed three times in PBS buffer for 5 
min. For TET1 and TET3 staining, the slides were developed for 1 h using the 
VECTASTAIN Elite ABC-AP system (Vector, Peterborough, UK) and 
visualized with SIGMAFAST Fast Red (Sigma Aldrich, St. Louis, USA) for 10 
min. For TET2 staining of human testis tissue slides, VECTASTAIN Elite 
ABC-Peroxidase (Vector, Peterborough, UK) and 3,3’-Diaminobenzidine (DAB) 
enhanced liquid substrate (Sigma-Aldrich, St. Louis, USA) systems were used. 
For TET2 staining in Hela cells and in human mature spermatozoa, ABC-AP 
system and Fast Red reagent were used as described above for TET1 and 
TET3 proteins. The reactions were terminated with distilled water, and the 
staining results were observed and documented using Leica ICC50 HD (Leica, 
Wetzlar, Germany). 
 
2.2.2 IF detection of 5hmC 
Slides with formalin-fixed paraffin-embedded human testis tissues were 
processed as described for IHC until the primary antibody step, and incubated 
over night at 4°C with the primary antibody (rat anti 5hmC: 1:300, Abcam, 
Cambridge, UK). After rinsing three times with Tris-HCl buffer, the slides were 
incubated with the secondary antibody (donkey anti rat IgG: 1:500, Abcam, 
Cambridge, UK) for 1 h and mounted with Vectashield® mounting medium with 
DAPI (Vector, Burlingame, USA). Images were analyzed and captured using 
Leica ICC50 HD (Leica, Wetzlar, Germany).  
 
2.2.3 WB analysis of TET1–3 proteins 
Mature spermatozoa from two healthy fertile donors and PC3 cells as 
positive control were used for WB analysis regarding TET1 (235 kDa), TET2 
(224 kDa) and TET3 (179 kDa) proteins. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH, 37 kDa) was applied as a reference protein. 
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In the step of protein isolation, 2 × 107 sperm cells were washed twice in 
PBS buffer containing protease inhibitors, pelleted by centrifugation at 10,000 
rpm (8940 × g), 4°C for 5 min, and re-suspended in 100 μl lysis buffer. PC3 
cells were washed twice in PBS buffer and suspended in 100 μl lysis buffer. 
Sperm cells and PC3 cells were then lysed on ice for 30 min with extra 
extensive vortex for five cycles, each 1 min. Sperm cells were additionally 
treated with Ultra Turrax (IKA, Staufen, Germany) for five cycles, each 30 sec. 
After centrifugation at 15,000 rpm (20,120 × g), 4°C for 30 min, the protein 
extracts were in the supernatant. Protein concentration was measured by 
Pierce BCA Protein Assay Kit (Thermo Scientific, Waltham, USA), and all 
protein samples were stored at -80°C. 
In total, 50 µg protein was mixed with 5 µl Laemmli loading buffer and 
denaturated at 95°C for 5 min. Samples were separated in a polyacryamid-gel 
(4% stacking gel and 7.5% separating gel) at 100 volt until the samples had 
gone through the stacking part, then turn up to 120 volt. Coomassie stain 
(ROTH, Karlsruhe, Germany) was used for visualization of proteins in gels. 
Semi-dry transfer method was used. PVDF-membranes were activated by 
methanol for 10 min. Three levels of Whatman filter paper were soaked in 
Cathode buffer and Anode buffer for 10 min, respectively. Cassette was 
prepared in the following order without bubbles: case (clear side), Whatman 
filter papers (Cathode buffer), gel, PVDF-membrane, Whatman filter papers 
(Anode buffer), case (black side), which was then placed in a semi-dry transfer 
cell (Bio-Rad, Munich, Germany) at 20 volt for 1 h. The PVDF-membrane was 
stained with 1 × Ponceau S for 10 min in order to check the transfer status. 
After blocking in 5% non-fat milk in 1 × TBST buffer for 2 h at RT, 
membranes were incubated with primary antibodies diluted in blocking buffer 
overnight at 4°C (rabbit anti TET1: 1:2000, GeneTex, San Antonio, USA; rabbit 
anti TET2: 1:1000, GeneTex, San Antonio, USA; rabbit anti TET3: 1:1000, 
GeneTex, San Antonio, USA; rabbit anti GAPDH: 1:5000, Sigma-Aldrich, St. 
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Louis, USA), washed three times with 1 × TBST buffer for 10 min, incubated 
with the secondary antibody diluted in blocking buffer (Goat anti rabbit 
IgG-HRP: 1:5000, GeneTex, San Antonio, USA) for 1 h at 37°C, and washed 
three times with 1 × TBST for 10 min. Membranes were then developed by 
Pierce ECL Western blotting substrate (Thermo Scientific, Waltham, USA) 
according to the protocol, and images were captured with the 
chemiluminescence image analyzer Fusion FX7 advanced (Vilber Lourmat, 
Eberhardzell, Germany). 
 
2.2.4 ISH analysis of TET1–3 mRNA expression 
Non-radioactive ISH was performed applying digoxygenin (DIG)-labelled 
cRNA probes (sense and anti-sense) to analyze TET1–3 mRNA expression 
during human spermatogenesis. Formalin-fixed and paraffin-embedded 
testicular tissue sections from patients with obstructive azoospermia exhibiting 
histological normal spermatogenesis were used in this study. 
The RNA template was isolated from HeLa cells with PeqGOLD TriFast 
(VWR, Erlangen, Germany), and reverse transcribed by M-MLV RT system 
(Promega, Mannheim, Germany). The cDNA was amplified for 40 cycles (initial 
denaturation 95°C for 5 min, cycling: 95°C for 30 sec, 60°C for 30 sec, 72°C for 
30 sec) with specific primer sets generated for TET1–3 (Table 1) using 
Mastercycler (Eppendorf, Wesseling-Berzdorf, Germany). PCR products were 
confirmed by separating on a 2% agarose gel, and extracted using NucleoSpin 
Gel and PCR clean-up kit (Macherey Nagel, Düren, Germany), which were 
cloned into the pGEM-T Vector (Promega, Mannheim, Germany) and 
transformed into XL1-blue strain competent Escherichia coli cells (Stratagene, 
Heidelberg, Germany) according to the manufacturer’s protocols. White 
colonies were picked and cultured in 5 ml LB/Ampicillin medium under shaking 
at 37°C overnight. The recombinant plasmid DNA was isolated by QIAprep 
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Spin Miniprep Kit (Qiagen, Hilden, Germany) according to the manufacturer’s 
protocol. The cloned inserts in the plasmid DNA were verified by sequencing 
with T7 and SP6 primers (T7 primer: 5’-TAATACGACTCACTATAGGG-3’ and 
SP6 primer: 5’-ATTTAGGTGACACTATAGAA-3’). After confirming that the 
inserts were in accordance with the designed TET1–3 PCR products (Figure 7), 
QIAfilter Plasmid Midi Kit (Qiagen, Hilden, Germany) was used to isolate the 
recombinant plasmid DNA from the positive E. coli cells. The isolated plasmid 
DNA was digested by NcoI and NotI restriction enzymes (Thermo Scientific, 
Waltham, USA). The cutting points of the enzymes are indicated in Figure 8. 
The DIG RNA Labeling Kit (SP6/T7) (Roche, Mannheim, Germany) was used 
according to the manufacturer’s protocol in order to produce sense and 
anit-sense non-radioactive DIG-labelled TET1–3 cRNA probes. The generated 
cRNA probes were stored at -80°C for ISH.  
Human testicular tissue slides were deparaffinized by soaking three times 
in xylol (each 10 min), twice in ethanol absolute (each 5 min), twice in 96% 
ethanol (each 5 min) and twice in 70% ethanol (each 5 min). The slides were 
then rinsed in DEPC water for 5 min, soaked in 0.2 N HCl for 20 min and in 2 × 
SSC buffer at 70°C for 15 min, washed in PBSM buffer for 5 min, and treated 
with proteinase K (20 mg/ml) for 10 min at 37°C. After soaking in 0.2% glycin 
solution for 5 min, 20% acetic acid for 20 sec, washed in PBSM buffer for 5 min, 
sections were post-fixed in 4% PFA solution for 10 min and incubated in 20% 
glycerol for 1 h. Slides were then initially incubated at 70°C for 10 min with 
1:200 dilution of DIG-labelled sense or anti-sense TET1–3 cRNA probes in 
hybridization buffer, and then at 42°C in a humidified chamber overnight. In the 
post-hybridization step, the slides were washed four times with 4 × SSC buffer 
for 10 min at 42°C, with 2 × SSC buffer for 20 min at 60°C, 0.2 × SSC buffer for 
20 min at 42°C, 0.1 × SSC buffer for 5 min at RT, 2 × SSC buffer for 5 min at 
RT and finally with 1 × TNMT buffer for 10 min at RT. After blocking with 3% 
BSA for 1 h, the sections were incubated with 1:500 dilution of the secondary 
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antibody (sheep anti Dig-AP, Roche, Mannheim, Germany) at 4°C overnight. 
Subsequently, sections were washed twice with 1 × TNMT buffer for 10 min at 
RT, 1 × NTB buffer for 5 min and 1 × NTB buffer containing 1 mM levamisole 
for 5 min. The staining was visualized by developing with 
nitroblue-tetrazolium/5-bromo-4-chloro-3-indolylphosphate (NBT/BCIP, KPL, 
Gaithersburg, USA) for approximate 6 h in a humidified chamber protected 
from light. Images were observed and captured using Leica ICC50 HD (Leica, 
Wetzlar, Germany). 
 
Figure 7 The sequencing results of the cloned inserts in the plasmid DNA were 
accordance with the designed TET1–3 PCR products. 
 
Figure 8 The cutting points of Nco I and Not I restriction enzymes in the pGEM-T 
Vector circle map. 
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2.2.5 RNA extraction, cDNA synthesis and real-time PCR 
Patient RNAs were isolated from a minimum of 1.5 to a maximum of 70 
million sperm cells, and control RNAs were extracted from a minimum of 30 to 
a maximum of 70 million sperm cells (in total). RNA extraction of sperm cells 
was preformed using RNeasy Plus Micro and Mini Kits (Qiagen, Hilden, 
Germany). Prior to cDNA synthesis, putative contamination of genomic DNA 
was eliminated by DNase I (RNase-free) (Thermo Scientific, Waltham, USA) 
treatment according to the manufacturer’s protocol. After measuring RNA 
concentrations, the purified sperm RNA samples were stored at -80°C. First 
strand complementary DNA (cDNA) synthesis was performed using 100–300 
ng RNA with iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, USA) according 
to the manufacturer’s protocol. The generated cDNAs were then purified by 
QIAquick PCR Purification Kit (Qiagen, Hilden, Germany). After measurement 
of the purified cDNA concentrations, all sperm cDNA samples were stored at 
-20°C. 
Real-time PCRs were performed for TET1, TET2 and TET3 (Gene IDs: 
80312, 54790 and 200424, respectively), DNMT1 and DNMT3A (Gene IDs: 
1786 and 1788), and the reference gene GAPDH (Gene ID: 2597) with 
appropriate designed primer sets (Table 1) using Rotor-Gene Q PCR cycler 
(Qiagen, Hilden, Germany). GAPDH was shown to be an appropriate 
reference gene for RNA analyses in human mature sperm cells (Aoki et al. 
2006; Cavalcanti et al. 2011). For each sperm sample, 20–30 ng of cDNA were 
amplified using Rotor-Gene SYBR Green PCR Kit (Qiagen, Hilden, Germany) 
for 45 cycles (initial denaturation 95°C for 5 min, cycling: 95°C for 30 sec, 60°C 
for 30 sec, 72°C for 30 sec, and ended with incubation for 4 min at 72C) 
according to the manufacturer’s protocol, PCR products were confirmed by 
separating on a 2% agarose gel. All real-time PCR reactions were performed 
in duplicates. 
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Relative values of TET1–3, DNMT1 and DNMT3A mRNAs were 
calculated using an intern calibrator in order to compare differences between 
groups. In order to select an appropriate calibrator RNA, we measured TET1–3, 
DNMT1 and DNMT3A relative mRNA levels in sperm samples from three 
healthy donors. All three samples showed similar values for all TETs (TET1: 1, 
1.29 and 0.83; TET2: 1, 0.98 and 1.16; TET3: 1, 0.99 and 1.09, respectively) 
and possessed well detectable amounts of TET1–3 in sperm cells (confirmed 
by RT-PCR and Western blot), as well as DNMT1 (1, 1.13 and 0.92) and 
DNMT3A (1, 0.87 and 1.05). The first RNA sample was selected as the 
calibrator RNA. 
Table 1 Primer sets used for quantification of TET1–3, DNMT1, DNMT3A and 
GAPDH transcripts in human mature spermatozoa 
Gene Primer sequence (5'-3') for RT-qPCR PCR-product (bp) Tm (°C) 
TET1 
F: TCCTGGTGCTATTCCAGTCC; 
R: AAAGCCTTCATACATCTCAAG 
110 
58.80 
58.18 
TET2 
F: ACTCACCCATCGCATACCTC; 
R: TCAGCATCATCAGCATCACA 
113 
59.25 
57.30 
TET3 
F: CCCAGAGCTCCAACTGCTAC; 
R: GAGAATACGAAGAAGTTCATCA 
138 
60.11 
58.43 
DNMT1 
F: GAACGGTGCTCATGCTTACAA; 
R: TCTCCATCGGACTTGCTCCT 
159 
59.20 
60.32 
DNMT3A 
F: CCTGCAGAAGCGGGTGAG; 
R: ATATGCGCAGGCTGCATC 
183 
60.44 
58.34 
GAPDH 
F: TGGAGAAGGCTGGGGCTCAT; 
R: GACCTTGGCCAGGGGTGCTA 
176 
63.14 
64.04 
RT-qPCR: reverse transcription of RNA followed by quantitative real-time PCR; F: forward 
primer; R: reverse primer; Tm: primer melting temperature; bp: base pair. 
MATERIALS AND METHODS 
- 29 - 
 
2.2.6 COBRA of TET1–2 CpG-promoters and imprinted gene H19 
In order to analyze the methylation status of TET1–2 CpG-promoters in 
sperm cells, we selected subfertile patients with low mRNA level (TET1, n = 10; 
TET2, n = 10) and fertile donors with high mRNA expression (TET1, n=10; 
TET2, n = 11). Additionally, 18 subfertile patients and 20 fertile donors were 
chosen at random to check the methylation pattern of the imprinted gene H19 
in human mature spermatozoa. 
In the step of sperm DNA isolation, 1 × 107 sperm cells were washed twice 
with PBS buffer at 3500 rpm (1160 × g) for 10 min. The sperm pellet was 
re-suspended in 1 ml lysis buffer and incubated overnight at 56°C. A volume of 
1 ml phenol, 1ml phenol/chloroform and 1 ml chloroform was added separately, 
and the supernatant was collected each time with a centrifugation at 13,000 
rpm (16,060 × g), 4°C for 10 min. In order to precipitate sperm DNA, the 
superntant was mixed with 100 µl 3 M sodium acetate (NaOAc), 5 µl glycogen 
(20 mg/ml) and 1 ml isopropanol. The mixture was placed at -20°C for 30 min. 
Sperm DNA was precipitated by centrifuging at 13,000 rpm (16,060 × g) for 30 
min, washed with 70% ethanol and dissolved in 20 µl DEPC water. DNA 
concentrations were then measured, and all samples were stored at -20°C. 
Bisulfite treatment of sperm DNAs from all participants was performed 
using EpiMark® Bisulfite Conversion Kit (New England Biolabs, Ipswich, USA) 
according to the manufacturer’s protocol. COBRA PCR was performed using 
20 ng bisulfite-treated sperm DNA as template. Specifically, the designed 
COBRA primers of TET1–2 (Gene IDs: 80312, 54790) and the imprinted gene 
H19 (Gene ID: 283120) (Table 2), together with MyTaq™ mix (Bioline, MA, 
USA), were used for PCR amplification in a thermal cycler (Bio-Rad, Munich, 
Germany) for 45 cycles (initial denaturation 95°C for 3 min, cycling: 95°C for 30 
sec, 60°C (TET1–2) or 63°C (H19) for 30 sec, 72°C for 30 sec, and ended with 
incubation for 5 min at 72C) according to the manufacturer’s protocol. Based 
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on their PCR sequence, amplified products were digested with Bsh1236I 
(BstUI) restriction enzyme (Thermo Scientific, Waltham, USA). Mock digestion 
(no Bsh1236I enzyme) was included as negative controls. Bisulfite-treated 
DNA of LNCaP cells and M.SssI-treated (Thermo Scientific, Waltham, USA) 
sperm DNA were used as positive controls. The digested products were 
checked on a 2% agarose gel to identify the methylation status. Images were 
examined and captured by the gel documentation system BioDocAnalyze 
(Biometra, Göttingen, Germany). 
Table 2 Primer sets used for methylation analyses of TET1–2 CpG-promoters 
and H19 DMRs in human sperm cells 
Gene Primer sequence (5'-3') for COBRA 
PCR-product 
(bp) 
Tm 
(°C) 
Restriction 
enzyme* 
TET1 
F: GTTTTGGGGAGATATTGTTGTTT; 
R: CCCTcrAACAAACTTTCCAA 
333 
55.63 
Bsh1236I 
60.08 
TET2 
F: ATTTYgAAGTGGTGGTGGAG; 
R: ACCCTCAcrCcrTACAATAA 
272 
59.97 
Bsh1236I 
60.39 
H19 
F: GGGGGTTTTTGTATAGTATATGGGTA; 
R: CCCATAAATATCCTATTCCCAAATAAC 
239 
58.01 
Bsh1236I 
56.17 
COBRA: combined bisulfite restriction analysis; DMRs: differentially methylated regions; F: 
forward primer; R: reverse primer; Tm: primer melting temperature; bp: base pair. 
Restriction recognition sites (5’-3’): Bsh1236I (CG..CG) 
 
2.2.7 Bisulfite pyrosequencing of TET3 CpG-promoter 
For the methylation status analysis at TET3 CpG-promoter, we selected 
10 subfertile patients with low TET3-mRNA level and 10 fertile donors with high 
TET3-mRNA expression. 
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The specific PCR primers of TET3 (Gene ID: 200424) were from 
pre-designed PyroMark CpG assay of Qiagen (PM00103495, Qiagen, Hilden, 
Germany). The specific analyzed sequence for TET3 included 6 CpG-sites (Y): 
“ATTGYGTTTTYGGGTGGAGYGGAGYGGAGTAGAYGTYGGGGGGGT”. 
Bisulfite pyrosequencing PCR reactions of TET3 were performed as TET1–2 
COBRA PCR program. Amplified PCR products (250 bp) were checked on a 
2% agarose gel. Bisulfite pyrosequencing was performed using PyroMark Gold 
Q24 Reagents (Qiagen, Hilden, Germany) on a Pyromark Q24® instrument 
(Qiagen, Hilden, Germany) according to the manufacturer’s guideline. 
 
2.2.8 Statistical analysis 
Data were analyzed using the SPSS 19.0 software (IBM, Chicago, IL, 
USA). Values are shown as mean and range (minimum to maximum) for 
semen parameters, and mean ± standard error of the mean (SEM) as well as ± 
standard deviation (SD) are given for mRNA analyses. SEM takes into account 
both the value of SD and ample size, and quantifies how precisely the mean of 
the studied population is. SD represents the degree of dispersion within the 
studied population. Data distributions were evaluated using the 
Kolmogorov-Smirnov test. Non-parametric variables were compared by the 
Mann–Whitney U-test. Receiver operating characteristic (ROC) curve analysis 
was used to assess the ability of TET1–3, DNMT1 and DNMT3A mRNA level 
as a means of distinguishing fertile and subfertile men, low and high 
fertilization groups, and pregnant and non-pregnant couples concerning ICSI 
treatment. Correlations between variables were calculated using the 
Spearman’s non-parametric method. Statistical significance was considered at 
P < 0.05 (moderately significant) and P < 0.01 (highly significant). 
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3. RESULTS 
3.1 TET1–3 show a stage-specific expression during the human 
seminiferous epithelial cycle 
Formalin-fixed and paraffin-embedded tissue sections of human testes 
from patients with obstructive azoospermia exhibiting histological normal 
spermatogenesis were used to analyze the expression of TET1–3 mRNA and 
protein during human spermatogenesis. 
 
3.1.1 TET1 
TET1-mRNA started to express in the cytoplasm of the early pachytene 
spermatocytes in stage I and was detectable up to the late pachytene 
spermatocytes in stage V (Figures 9B–C). In contrast to TET1-mRNA, TET1- 
protein was detectable after the differentiation of pachytene spermatocytes 
starting to express in the nuclei of step 1 round spermatids in stage I and 
remaining up to step 4 elongating spermatids in stage IV (Figures 10A–C). 
 
Figure 9 In-situ hybridization for the detection of TET1-mRNA in human testicular 
tissue sections. TET1-mRNA is present in the cytoplasm of pachytene spermatocytes 
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starting in stage I up to stage V. While cartoons summarize depicted TET1-mRNA in 
blue circles (A), B and C show two exemplary tubules with different stages of the 
seminiferous epithelial cycle (Roman numbers). Negative staining (D) represents the 
serial section of C. Primary magnification (PM) × 400; scale bars (SB) 10 µm. 
 
Figure 10 Immunohistochemistry for the detection of TET1-protein in human 
testicular tissue sections. TET1-protein starts to be expressed in the nuclei of step 1 
round spermatids in stage I and is detectable until step 4 elongating spermatids in stage 
IV. A–C show three exemplary tubules with different stages of the seminiferous epithelial 
cycle (Roman numbers). Negative staining (D) represents the serial section of C. 
Cartoons summarize depicted TET1-protein in red circles (E). PM × 400; SB 10 µm. 
 
3.1.2 TET2 
The expression pattern of TET2-mRNA was identical to that of TET1- 
mRNA starting in the cytoplasm of pachytene spermatocytes from stage I up 
to stage V (Figures 11B–C). TET2-protein, in contrast, occurred solely in the 
cytoplasm of the late pachytene spermatocytes of stage V (Figures 12B–C). 
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Figure 11 In-situ hybridization for the detection of TET2-mRNA in human testicular 
tissue sections. TET2-mRNA is present in the cytoplasm of pachytene spermatocytes 
starting in stage I up to stage V. While cartoons summarize depicted TET2-mRNA in 
blue circles (A), B and C show two exemplary tubules with different stages of the 
seminiferous epithelial cycle (Roman numbers). Negative staining (D) represents the 
serial section of C. PM × 400; SB 10 µm. 
 
Figure 12 Immunohistochemistry for the detection of TET2-protein in human 
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testicular tissue sections. TET2-protein is detected only in the cytoplasm of late 
pachytene spermatocytes of stage V. While cartoons summarize depicted TET2-protein 
in a red circle (A), B and C show two exemplary tubules with different stages of the 
seminiferous epithelial cycle (Roman numbers). Negative staining (D) represents the 
serial section of C. PM × 400; SB 10 µm. 
 
3.1.3 TET3 
Signals for TET3-mRNA were identical to that of TET1- and 
TET2-mRNAs, which could be observed in the cytoplasm of pachytene 
spermatocytes from stage I to V (Figures 13B–C). TET3-protein appeared in 
the nuclei of step 3 round spermatids of stage III and step 4 elongating 
spermatids of stage IV (Figures 14B–C).  
 
Figure 13 In-situ hybridization for the detection of TET3-mRNA in human testicular 
tissue sections. TET3-mRNA is present in the cytoplasm of pachytene spermatocytes 
from stage I up to stage V. While cartoons summarize depicted TET3-mRNA in blue 
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circles (A), B and C show two exemplary tubules with different stages of the 
seminiferous epithelial cycle (Roman numbers). Negative staining was a tubule 
exhibiting stages III, IV and V (D). PM × 400; SB 10 µm. 
 
Figure 14 Immunohistochemistry for the detection of TET3-protein in human 
testicular tissue sections. TET3-protein is detectable in the nuclei of step 3 round 
spermatids in stage III and step 4 elongating spermatids in stage IV. While cartoons 
summarize depicted TET3-protein in red circles (A), B and C show two exemplary 
tubules with different stages of the seminiferous epithelial cycle (Roman numbers). 
Negative staining (D) represents the serial section of C. PM × 400; SB 10 µm. 
 
3.2 Detection of 5hmC during normal human spermatogenesis 
All three members of the TET family possess methylcytosine 
dioxygenase activity and are important for DNA demethylation. Therefore, we 
also analyzed the occurrence of 5hmC during the human seminiferous cycle. 
Using IF staining, we could detect 5hmC only in elongated step 5 spermatids, 
whereas elongated step 7 and 8 spermatids lack 5hmC (Figure 15). 
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Figure 15 Detection of 5hmC in human testis exhibiting histological normal 
spermatogenesis. 5hmC could be detected by immunofluorescence in step 5 elongated 
spermatids of stage V, but not in steps 7 and 8 elongated spermatids (stage I and II, 
respectively). Negative control and DAPI (4′,6-diamidino-2-phenylindole) staining images 
are shown. PM × 400; SB 10 µm. 
 
3.3 Summary of TET1–3 expression and 5hmC during normal human 
spermatogenesis 
We found that TET1–3 mRNA profiles were identical: all started to 
express in the cytoplasm of early pachytene spermatocytes of stage I and 
were detectable up to late pachytene spermatocytes of stage V. Interestingly, 
TET1–3 protein expressions occurred successively starting with TET2, which 
could be detected solely in the cytoplasm of the late pachytene 
spermatocytes of stage V, followed by TET1 starting to express in the nuclei 
of step 1 round spermatids of stage I and remaining up to step 4 elongating 
spermatids of stage IV. Finally, TET3 appeared in nuclei of step 3 round 
spermatids of stage III and was detectable until step 4 elongating spermatids 
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of stage IV. We could also detect 5hmC only in the elongated step 5 
spermatids, whereas elongated steps 7 and 8 spermatids were free of 5hmC 
(Figure 16). 
 
Figure 16 Schematic overview demonstrates that TET1–3 and 5hmC are expressed 
at different stages during the human seminiferous epithelial cycle. TET1–3 mRNAs 
have the same expression profile, whereas the expressions of TET1–3 proteins are 
shifted. Blue lines: TET1–3 mRNAs; red lines: TET1–3 proteins; green line: 5hmC. 
 
3.4 Human ejaculated sperm cells contain considerable amounts of 
TET1–3 mRNA and protein 
After isolating total sperm RNA from three healthy donors, RT-PCR was 
applied to confirm the presence of TET1–3 mRNA in sperm cells. Specific 
bands of amplified RT-PCR products of TETs (TET1 = 110 bp, TET2 = 113 bp 
and TET3 = 138 bp) and GAPDH (176 bp, served as a reference gene) were 
visible on a 2% agarose gel (Figure 17). WB and ICC analyses confirmed the 
presence of non-degraded TET1–3 protein in human mature spermatozoa. In 
addition, total protein extracts were isolated from sperm cells of two healthy 
donors and PC3 cells (positive control for applied antibodies). Specific bands 
of TETs (TET1 = 235 kDa, TET2 = 224 kDa and TET3 = 179 kDa) and 
GAPDH (37 kDa, served as a reference protein) could be detected in WB 
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(Figure 18A). ICC analysis confirmed our WB results showing positive 
immunostaining for TET1–3 proteins in the nuclei of decondensed mature 
human spermatozoa and HeLa cells (positive control for applied antibodies) 
(Figure 18B). 
 
Figure 17 TET1–3 mRNA analyses in human mature spermatozoa. mRNA analysis 
of TET1 (110 bp), TET2 (113 bp) and TET3 (138 bp) using RT-PCR in sperm cells of 
fertile donors 1, 2 and 3. GAPDH was used as a reference gene (176 bp). 
 
Figure 18 Protein analyses of TET1–3 using WB and ICC in human mature 
spermatozoa. (A) WB results of TET1 (235 kDa), TET2 (224 kDa), TET3 (179 kDa) and 
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GAPDH (reference protein, 37 kDa) in sperm cells from fertile donors 1 and 2, and in 
PC3 cells (positive control for the applied antibodies). (B) ICC staining of TET1–3 
proteins in decondensed mature spermatozoa from two fertile donors (left: positive 
staining; right: negative staining) and in HeLa cells (positive control for the applied 
antibodies; inset). PM × 400; SB 10 µm. 
 
3.5 TET1–3, DNMT1 and DNMT3A mRNA levels in human sperm cells 
3.5.1 TET1–3 mRNA levels in heathy donors and subfertile patients  
A general comparison of healthy donors and subfertile patients (Figure 
19A), without differentiations concerning semen parameters, revealed that 
the relative TET1 and TET3 mRNA levels in sperm cells were much higher in 
healthy donors compared to subfertile patients (TET1: 1.45 ± 0.24 (± 1.97) 
versus 0.77 ± 0.07 (± 0.69), P = 0.016; TET3: 1.67 ± 0.18 (± 1.55) versus 1.09 
± 0.09 (± 0.91), P = 0.015; mean ± SEM (± SD), Mann–Whitney U-test). The 
TET2 mRNA level did not differ significantly between these two groups (TET2: 
0.91 ± 0.09 (± 0.79) versus 0.74 ± 0.07 (± 0.66), P = 0.156, Mann–Whitney 
U-test). Furthermore, ROC curve analyses of TET1–3 mRNA levels were 
used to discriminate healthy donors and subfertile patients demonstrating that 
the AUC of TET1 and TET3 mRNAs were 0.611 (P = 0.015) and 0.610 (P = 
0.015), respectively, with the best discriminative cut-off value of 0.430 
(sensitivity = 42.55%, specificity = 74.29%) and 1.172 (sensitivity = 70.65%, 
specificity = 54.67%; Figure 20). However, the AUC of TET2 mRNA was only 
0.565 (P = 0.156). Comparisons of TET1–3 mRNA levels among themselves 
revealed significant positive correlations (P < 0.002, Spearman’s 
non-parametric correlation; Figures 19B–D). Semen parameters of controls 
and patients are given in Table 3.  
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Figure 19 RT-qPCR analyses of TET1–3 mRNA in sperm cells of fertile donors and 
subfertile patients, who underwent ICSI procedures with their female partners. (A) 
Comparison of TET1–3 mRNA levels in healthy donors and subfertile patients (relative 
mean values ± SEM, P-values, Mann–Whitney U-test, and number of analyzed samples 
are given). (B–D) Correlations among TET1–3 mRNA levels considering all sperm 
samples (Rs, P-values of Spearman’s non-parametric correlation are given). 
 
Figure 20 ROC curve analyses for TET1–3 mRNA levels in sperm cells. TET1 and 
TET3 mRNA levels, but not TET2, could efficiently distinguish between fertile donors and 
subfertile patients (AUC, P-values, cutoff-values, sensitivity and specificity are given). 
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Table 3 Semen parameters (TET1–3 study) of healthy men (control group) and 
subfertile patients who underwent ICSI-procedure with female partners 
(patient group) 
            Control group     Patient group      P-value* 
TET1: 
Number            70            94            – 
Mean age (min-max)      29.23 (19–54)   38.67 (28–55)   < 0.0001 
Partner age        Not available      35.13 (25–45)   Not available 
Concentration (× 10
6
/ml)  71.49 (15.6–310)  43.80 (2.2–243)      < 0.0001 
Total sperm count (× 10
6
)  257.51 (43.2–930)  161.55 (3.4–1021)  < 0.0001 
Progressive motility (%)  63.06 (34–89)   40.40 (6–64)   < 0.0001 
Total motility (%)       71.40 (40–91)   62.86 (25–82)   < 0.0001 
Normal morphology (%)  15.74 (4–34)   5.21 (0–13)       < 0.0001 
TET2 and TET3: 
Number            75            92            – 
Mean age (min-max)   29.20 (19–54)   38.21 (28–50)   < 0.0001 
Partner age        Not available   34.97 (26–45)   Not available 
Concentration (× 10
6
/ml)  77.69 (15.6–310)  43.70 (1–243)      < 0.0001 
Total sperm count (× 10
6
)  289.94 (43.2–1384)  154.07 (0.8–1021)  < 0.0001 
Progressive motility (%)  63.00 (34–89)   40.43 (6–64)   < 0.0001 
Total motility (%)       71.20 (40–91)   63.02 (25–83)   < 0.0001 
Normal morphology (%)    15.65 (4–34)   4.92 (1–13)       < 0.0001 
P-values are calculated by Mann-Whitney U-test. 
 
3.5.2 DNMT1 and DNMT3A mRNA levels in healthy donors and subfertile 
patients 
After isolating the total sperm RNA from 48 healthy donors and 48 
subfertile patients, RT-qPCR was used to measure relative DNMT1 and 
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DNMT3A mRNA levels with specific bands of 159 bp and 183 bp for amplified 
DNMT1 and DNMT3A RT-PCR products, respectively (Figure 21A). Semen 
parameters of controls and patients are given in Table 4. 
In general, our data demonstrated that DNMT1 and DNMT3A mRNA 
levels in sperm cells were much higher in healthy donors compared to the 
patients (DNMT1: 1.49 ± 0.14 (± 0.96) versus 0.96 ± 0.08 (± 0.53), P = 0.011; 
DNMT3A: 2.27 ± 0.17 (± 1.21) versus 0.69 ± 0.10 (± 0.72), P < 0.0001, 
Mann–Whitney U-test; Figure 21B). ROC curve analyses of DNMT1 and 
DNMT3A mRNAs were applied in order to discriminate healthy donors and 
subfertile patients (Figure 21B). The AUC of DNMT1 and DNMT3A mRNAs 
were 0.650 (P = 0.011) and 0.904 (P < 0.0001) respectively with the best 
cutoff value of 1.518 (sensitivity = 91.67%, specificity = 52.08%) and 0.630 
(sensitivity = 81.25%, specificity = 95.83%). Furthermore, a significant 
positive correlation was found between DNMT1 and DNMT3A mRNAs (Rs = 
0.520, P < 0.0001, Spearman’s non-parametric correlation; Figure 21C).  
 
Figure 21 RT-qPCR analyses of DNMT1 and DNMT3A mRNAs in sperm cells of 
fertile donors and subfertile patients, who underwent ICSI treatment with their 
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female partners. (A) DNMT1 (159 bp) and DNMT3A (183 bp) RT-PCR amplified 
products of mature human spermatozoa from fertile donors 1, 2 and 3. (B) Comparison 
of DNMT1 and DNMT3A mRNA levels in donor and patient groups (relative mean values 
± SEM, P-values and number of analyzed samples are given; Mann–Whitney U-test). 
Furthermore, ROC curve analyses for DNMT1 and DNMT3A mRNAs in sperm 
distinguishing between fertile donors and subfertile patients (AUC, P-values, cutoff, 
sensitivity and specificity are given). (C) A significant positive correlation between 
DNMT1 and DNMT3A mRNA levels considering all sperm samples (Rs, P-values of 
Spearman’s non-parametric correlation are given).  
 
Table 4 Semen parameters (DNMT1 and DNMT3A study) of healthy men 
(control group) and subfertile patients who underwent ICSI-procedure with 
female partners (patient group) 
              Control group  Patient group      P-value* 
DNMT1 and DNMT3A: 
Number             48         48        – 
Mean age (min-max)       26.83 (19–46)    38.98 (30–50)   < 0.0001 
Partner age         Not available    35.33 (27–45)   Not available 
Concentration (× 10
6
/ml)   78.46 (16–256.5)   34.93 (1.2–219)  < 0.0001 
Total sperm count (× 10
6
)   247.32 (33.6–683)   119.66 (5.1–491)  < 0.0001 
Progressive motility (%)   63.10 (38–85)    37.94 (9–62)   < 0.0001 
Total motility (%)        71.06 (38–89)    60.83 (25–83)   < 0.0001 
Normal morphology (%)   19.42 (5–42)    3.13 (0–6)       < 0.0001 
* P-values are calculated by Mann-Whitney U-test. 
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3.5.3 TET1–3, DNMT1 and DNMT3A mRNA levels in subfertile patients 
with oligo- and asthenozoospermia 
We separated the subfertile patients suffering from oligozoospermia 
and/or asthenozoospermia in one “O + A” group (TET1: n = 39, TET2–3: n = 
36, DNMT1 and DNMT3A: n = 20), and compared them with the healthy 
donors and with the subfertile patients exhibiting normozoospermia “NZS” 
(TET1: n = 19, TET2–3: n = 17, DNMT1 and DNMT3A: n = 28; Figure 22).  
Our data demonstrated that TET1- (1.45 ± 0.24 (± 1.97), mean ± SEM (± 
SD)) and DNMT3A-mRNA (2.27 ± 0.17 (± 1.21)) levels in the healthy donors 
were significantly higher than whatever in the “O + A” or “NZS” subfertile 
patients (TET1: 0.59 ± 0.08 (± 0.48), P = 0.002, 0.39 ± 0.07 (± 0.30), P = 
0.0003; DNMT3A: 0.96 ± 0.23 (± 1.03), P < 0.0001, 0.49 ± 0.05 (± 0.26), P < 
0.0001, Mann–Whitney U-test), and the differences of TET2-, TET3-, 
DNMT1-mRNA levels were only observed between the healthy donors and “O 
+ A” subfertile patients (TET2: 0.91 ± 0.09 (± 0.79) versus 0.75 ± 0.15 (± 0.93), 
P = 0.028;  TET3: 1.67 ± 0.18 (± 1.55) versus 0.90 ± 0.11 (± 0.63), P = 0.047; 
DNMT1: 1.49 ± 0.14 (± 0.96) versus 0.92 ± 0.16 (± 0.73), P = 0.023, 
Mann–Whitney U-test; Figure 22). Overall, we found that the “O + A” 
subfertile patients revealed severely reduced TET1–3, DNMT1 and DNMT3A 
mRNA levels in human sperm cells, and the “NZS” subfertile patients 
exhibited significant decreases of TET1- and DNMT3A-mRNA expressions. 
Semen parameters including sperm concentration, total sperm count and 
sperm progressive and total motility of the “O + A” and “NZS” groups are 
given in Table 5. 
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Table 5 Semen parameters of analyzed healthy men (controls), subfertile men 
suffering from oligozoospermia and/or asthenozoospermia (O + A patients), 
and subfertile men exhibiting normoozoospermia (NZS patients) 
              Controls          O+A Patientsa  NZS Patients 
TET1: 
Number           70          39        19 
Concentration (× 10
6
/ml)   71.49 (15.6–310)     16.09 (2.2–86)*   82.14 (15–219)** 
Total sperm count (× 10
6
)  257.51 (43.2–930)    43.34 (3.4–240.8)*  294.20 (46.5–706)** 
Progressive motility (%)    63.06 (34–89)     29.54 (6–55)*       51.74 (37–60)** 
Total motility (%)      71.40 (40–91)     50.18 (25–82)*      75.11 (65–82)** 
TET2 and TET3: 
Number           75          36        17 
Concentration (× 10
6
/ml)   77.69 (15.6–310)    14.43 (1–86)*       75.60 (15–137)** 
Total sperm count (× 10
6
)  289.94 (43.2–1384)   40.22 (0.8–240.8)*  258.89 (46.5–511)** 
Progressive motility (%)    63.00 (34–89)     28.72 (6–54)*      51.12 (37–60)** 
Total motility (%)      71.20 (40–91)     49.25 (25–82)*      74.82 (65–82)** 
DNMT1 and DNMT3A 
Number           48           20        28 
Concentration (× 10
6
/ml)   78.46 (16–256.5)    12.22 (1.2–57)*   51.14 (15–219)** 
Total sperm count (× 10
6
)  247.32 (33.6–683)    35.49 (5.1–136.8)*  179.78 (37–491)** 
Progressive motility (%)    63.10 (38–85)     26.50 (9–54)*      46.11 (32–62)** 
Total motility (%)      71.06 (38–89)     47.15 (30–66)*      70.61 (53–83)** 
a 
Description of (O + A) group: in total 10 oligo-, 21 oligoastheno- and 8 
asthenozoospermia patients were available in our study. One asthenozoospermia 
patient exhibited in total 240 million sperm cells and had a 27% progressive motility; 
mean values (minimum to maximum) are given. 
* P < 0.01 (O + A vs. controls; Mann-Whitney U-test); ** P < 0.01 (O + A patients vs. NZS 
patients; Mann-Whitney U-test).
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Figure 22 TET1–3 (A), DNMT1 and DNMT3A (B) mRNA levels in mature sperm cells 
of subfertile patients suffering oligozoospermia and/or asthenozoospermia (O + A) 
in comparison with normozoospermic (Normal) patients and healthy donors. 
Relative mean values ± SEM, P-values, Mann–Whitney U-test, and number of analyzed 
samples are indicated. 
 
3.5.4 Associations of TET1–3, DNMT1 and DNMT3A mRNA levels with 
male age and seminal parameters 
We performed a descriptive analysis by comparing values of TET1–3, 
DNMT1 and DNMT3A relative mRNA levels to different parameters including 
age and semen quality parameters (Table 6). Here, we considered the whole 
study collective with the respective data for each person without separating 
into the control and patient groups.  
Highly significant negative correlations were observed between age and 
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the levels of TET1 (Rs = – 0.209, P = 0.007), TET3 (Rs = – 0.193, P = 0.013), 
DNMT1 (Rs = – 0.334, P = 0.0009) and DNMT3A (Rs = – 0.387, P < 0.0001) 
mRNAs in human mature spermatozoa (Spearman’s non-parametric 
correlation). Moreover, the correlations of semen parameters with TET1–3, 
DNMT1 and DNMT3A mRNA levels were described: (1) significant positive 
correlations were found between sperm concentration and TET1 (Rs = 0.182, 
P = 0.020), TET2 (Rs = 0.223, P = 0.004), TET3 (Rs = 0.169, P = 0.029) and 
DNMT3A (Rs = 0.270, P = 0.008) mRNA levels; (2) positive correlations were 
indicated between sperm progressive motility and TET1 (Rs = 0.261, P = 
0.0008), TET3 (Rs = 0.189, P = 0.014) and DNMT3A (Rs = 0.293, P = 0.004) 
mRNA levels; (3) a positive correlation of sperm total motility was observed 
with TET1 mRNA level (Rs = 0.210, P = 0.007); and (4) positive correlations 
of normal morphology were indicated with TET1 (Rs = 0.210, P = 0.043), 
DNMT1 (Rs = 0.365, P = 0.015) and DNMT3A (Rs = 0.388, P = 0.009) mRNA 
levels (Spearman’s non-parametric correlation).  
Table 6 Associations of TET1–3, DNMT1 and DNMT3A mRNA levels in mature 
human spermatozoa with male age and seminal parameters 
 
Rs, P-values of Spearman’s non-parametric correlation are given. 
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3.5.5 Correlations of TET1–3, DNMT1 and DNMT3A mRNA levels with 
fertilization rate after ICSI treatment 
Based on the threshold of fertilization rate (FR) as 70% after ICSI 
treatment (van Golde et al. 2001; Tournaye et al. 2002; Palermo et al. 2009; 
Rogenhofer et al. 2013), the subfertile patients were divided into two groups 
“low FR” (< 70%) and “high FR” (≥ 70%), and compared concerning TET1–3, 
DNMT1 and DNMT3A mRNA levels in sperm cells.  
In general, considering TET1–3 mRNA levels, the healthy controls 
showed the highest TET1–3 mRNA values in comparison with both “low FR” 
and “high FR” subfertile patients. A remarkable difference could be observed 
among patients for TET3-mRNA: “low FR” men had significantly reduced 
TET3-mRNA expression in sperm cells in comparison with “high FR” (0.87 ± 
0.12 (± 0.79) versus 1.33 ± 0.15 (± 1.01), P = 0.005), and with healthy donors 
(1.67 ± 0.18 (± 1.55), P = 0.001, Mann–Whitney U-test; Figure 23A). The best 
cut-off value of TET3-mRNA for differentiation between “low FR” and “high 
FR” groups was calculated at 1.022 (AUC = 0.672, P = 0.005, sensitivity = 
69.57% and specificity = 62.79%), and the calculated correlation coefficient 
was 0.314 (P = 0.003, Spearman’s non-parametric correlation; Figures 
23B–C). In contrast, no correlations of TET1–2 mRNA levels were detected 
between “low FR” and “high FR” groups (TET1: 0.75 ± 0.07 (± 0.50) versus 
0.78 ± 0.13 (± 0.85), P = 0.534; TET2: 0.68 ± 0.09 (± 0.64) versus 0.80 ± 0.11 
(± 0.70), P = 0.347; Mann–Whitney U-test; Figure 23A). 
On the other hand, regarding DNMT1 and DNMT3A mRNA levels, in 
general the healthy donors indicated the highest DNMT1 (1.49 ± 0.14 (± 0.96)) 
and DNMT3A (2.27 ± 0.17 (± 1.21)) mRNA values compared to both “low FR” 
and “high FR” men (Figure 24A). However, no differences could be found 
between “low FR” and “high FR” patients for DNMT1 (0.93 ± 0.13 (± 0.63) 
versus 0.95 ± 0.11 (± 0.48), P = 0.618) and DNMT3A (0.77 ± 0.20 (± 0.96) 
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versus 0.66 ± 0.10 (± 0.45), P = 0.401) mRNA levels (Mann–Whitney U-test; 
Figure 24A). There were no correlations between fertilization rate and the 
mRNA levels of DNMT1 (Rs = – 0.145, P = 0.421) and DNMT3A (Rs = – 
0.108, P = 0.481, Spearman’s non-parametric correlation; Figure 24B).  
 
Figure 23 Associations of TET1–3 mRNA levels in sperm cells with fertilization 
rates (FRs) after ICSI treatment. (A) Patients were divided into two subgroups (high FR 
≥ 70% and low FR < 70%), and compared to the healthy donors concerning TET1–3 
mRNA (relative mean values ± SEM, P-values of Mann–Whitney U-test, and number of 
analyzed samples are given). (B) Correlations of TET1–3 mRNA with FRs (Rs- and 
P-values, Spearman’s non-parametric correlation). (C) ROC curve analyses for TET1–3 
mRNA distinguishing between subfertile patients with low and high FRs (AUC, P-values, 
cut-off, sensitivity and specificity are given).  
RESULTS 
- 51 - 
 
 
Figure 24 Association studies of DNMT1 and DNMT3A relative mRNA levels in 
sperm cells with fertilization rates (FRs) after ICSI treatment. (A) The comparisons 
of DNMT1 and DNMT3A mRNA levels between patients with low FR (< 70%) and high 
FR (≥ 70%), and the comparisons with healthy donors (relative mean values ± SEM, 
P-values of Mann–Whitney U-test, and number of analyzed samples are given). (B) 
Correlations of DNMT1 and DNMT3A mRNA levels with FRs (Rs- and P-values, 
Spearman’s non-parametric correlation). 
 
3.5.6 Correlations of TET1–3, DNMT1 and DNMT3A mRNA levels with 
pregnancy status after ICSI treatment 
Considering the pregnancy status after ICSI (pregnant versus 
non-pregnant), the overall achieved pregnancy rates for couples analyzed in 
this study were 39.77% in the TET1 study (pregnant, n = 35; non-pregnant, n 
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= 53), 40.48% in the TET2–3 study (pregnant, n = 34; non-pregnant, n = 50) 
and 52.08% in the DNMT1 and DNMT3A study (pregnant, n = 25; 
non-pregnant, n = 23). In this part we aimed to investigate the correlations of 
TET1–3, DNMT1 and DNMT3A mRNA levels with the pregnancy status and 
the final outcome of the ICSI treatment. 
In general, in terms of TET1–3 mRNA levels, the men in the 
“non-pregnant” group showed the lowest TET1–3 mRNA levels in comparison 
with controls (TET1: 1.45 ± 0.24 (± 1.97) versus 0.70 ± 0.07 (± 0.54), P = 
0.011; TET2: 0.91 ± 0.09 (± 0.79) versus 0.60 ± 0.09 (± 0.60), P = 0.009; 
TET3: 1.67 ± 0.18 (± 1.55) versus 0.98 ± 0.11 (± 0.81), P = 0.009; mean ± 
SEM (± SD), Mann–Whitney U-test) and with men in the “pregnant” group 
(Figure 25A). Interestingly, by comparing “non-pregnant” and “pregnant” 
groups, we found a highly significant association between high level of TET2 
mRNA in sperm cells and pregnancy status after ICSI treatment (0.91 ± 0.12 
(± 0.72) versus 0.60 ± 0.09 (± 0.60), P = 0.005, Mann–Whitney U-test). The 
best cut-off value of TET2-mRNA for differentiation between “non-pregnant” 
and “pregnant” groups was calculated at 0.540 (AUC = 0.680, P = 0.005, 
sensitivity = 76.47% and specificity = 56.00%; Figure 25B). Nevertheless, no 
differences in TET1 and TET3 mRNA levels were detected between 
“non-pregnant” and “pregnant” groups (TET1: 0.70 ± 0.07 (± 0.54) versus 
0.93 ± 0.15 (± 0.89), P = 0.319; TET3: 0.98 ± 0.11 (± 0.81) versus 1.16 ± 0.15 
(± 0.87), P = 0.245; Mann–Whitney U-test; Figure 25A). On the other hand, 
the highest level of DNMT1 (1.49 ± 0.14 (± 0.96)) and DNMT3A (2.27 ± 0.17 
(± 1.21)) mRNAs occurred in the healthy donors compared to both 
“non-pregnant” and “pregnant” men (Figure 26). Nevertheless, no differences 
were detected between “non-pregnant” and “pregnant” patients for DNMT1 
(0.99 ± 0.13 (± 0.61) versus 0.93 ± 0.09 (± 0.44), P = 0.642) and DNMT3A 
(0.72 ± 0.18 (± 0.88) versus 0.66 ± 0.11 (± 0.55), P = 0.235) mRNA levels 
(Mann–Whitney U-test; Figure 26).  
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Figure 25 Associations of TET1–3 mRNA levels in sperm cells with pregnancy 
status after ICSI treatment. (A) Subfertile patients were divided into “pregnant” and 
“non-pregnant” groups, and compared with healthy donors concerning TET1–3 mRNA 
expressions in sperm cells (relative mean values ± SEM, P-values of Mann–Whitney 
U-test, and number of analyzed samples are given). (B) ROC curve analyses for TET1–3 
mRNA levels distinguishing between “pregnant” and “non-pregnant” groups after ICSI 
treatment (AUC, P-values, cut-off, sensitivity and specificity are given). 
 
Figure 26 Associations of DNMT1 and DNMT3A relative mRNA levels in sperm 
cells with pregnancy status after ICSI treatment. The comparison of DNMT1 and 
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DNMT3A mRNA levels between “pregnant” and “non-pregnant” groups, and the 
comparisons with healthy donors as well (relative mean values ± SEM, P-values of 
Mann–Whitney U-test, and number of analyzed samples are given). 
 
3.6 TET1–3 CpG-promoter methylation analyses in human sperm cells 
Previous results from this study found that low TET1–3 mRNA 
expressions in sperm cells are associated with male fertility and affected the 
outcome of ICSI treatment. Since DNA methylation at CpG-promoters may 
affect mRNA transcription, we aimed to investigate TET1–3 CpG-promoter 
methylation status in human sperm cells. 
 
3.6.1 TET1 CpG-promoter methylation status 
Based on the former results of TET1-mRNA level measured by RT-qPCR, 
10 semen samples with low TET1-mRNA expression from subfertile patients 
and an additional 10 semen samples with high TET1-mRNA expression from 
healthy donors were used to analyze the methylation status by COBRA 
analysis (0.55 ± 0.10 (± 0.33) versus 1.59 ± 0.14 (± 0.44), P < 0.0001, 
Mann–Whitney U-test; Figure 27A). Specific designed COBRA primers of 
TET1 CpG-promoter were used for PCR amplification (333 bp) products with 
6 restriction recognition sits (CG..CG) digested by Bsh1236I restriction 
enzyme (Figure 27B). Bisulfite-treated DNAs from LNCaP cells and 
M.SssI-treated sperm DNA were used as positive controls in order to ensure 
the accuracy of TET1-COBRA primers and Bsh1236I restriction enzyme 
(Figure 27D). Our results showed that TET1 CpG-promoters in sperm cells, in 
general, were unmethylated regardless of healthy donors or subfertile 
patients, while partially methylated and hypermethylated promoters were 
observed in LNCaP cells and M.SssI-treated sperm DNA (M.SssI), 
respectively (Figures 27C–D).  
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Figure 27 COBRA analysis of sperm TET1 CpG-promoter methylation in men with 
low (subfertile patients, n = 10) and high (healthy donors, n = 10) TET1-mRNA 
expression. (A) Comparison of sperm TET1 relative mRNA level in the selected donors 
and patients (relative mean values ± SEM, P-values of Mann–Whitney U-test, and 
number of analyzed samples are given). (B) A schematic overview of TET1 
CpG-promoter and the selected assay containing 6 CG..CG restriction recognition sites 
(brown line: CpG-island in the nucleotide strand, yellow line: selected assay for COBRA 
analysis). (C–D) Sperm TET1 CpG-promoters in both donor and patient groups were 
unmethylated, while the CpG-promoters of positive control groups including LNCaP cells 
and M.SssI-treated sperm DNA (M.SssI) were partially methylated and hypermethylated, 
respectively (“+” means digestion with Bsh1236I restriction enzyme, “-” means mock 
digestion). 
RESULTS 
- 56 - 
 
3.6.2 TET2 CpG-promoter methylation status 
Using COBRA analysis, we investigated the methylation status in men 
with low (n = 11, subfertile patients) and high (n = 10, healthy donors) 
TET2-mRNA levels (0.35 ± 0.10 (± 0.31) versus 1.30 ± 0.14 (± 0.48), P = 
0.0002, Mann–Whitney U-test; Figure 28A). The Bsh1236I restriction enzyme 
was used to digest TET2 CpG-promoter COBRA PCR amplification (272 bp) 
products with 4 CG..CG sites (Figure 28B). We found that TET2 
CpG-promoters in sperm cells were unmethylated in all selected participants 
no matter healthy donors and subfertile patients, while LNCaP cells and 
M.SssI-treated sperm DNA (M.SssI) exhibited hypermethylated 
CpG-promoters (Figures 28C–D). 
 
Figure 28 Sperm TET2 CpG-promoter methylation status was analyzed in men with 
low (subfertile patients, n = 10) and high (healthy donors, n = 11) TET2-mRNA 
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expression by COBRA analysis. (A) Comparison of sperm TET2-mRNA level in the 
selected healthy donors and subfertile patients (relative mean values ± SEM, P-values of 
Mann–Whitney U-test, and number of analyzed samples are given). (B) A schematic 
overview of TET2 CpG-promoter and the selected assay containing 4 CG..CG restriction 
recognition sites (brown line: CpG-island in the nucleotide strand, yellow line: selected 
assay for COBRA). (C–D) Sperm TET2 CpG-promoters in the donor and patient groups 
were both unmethylated, while promoters of positive control groups, LNCaP cells and 
M.SssI-treated sperm DNA (M.SssI), were both hypermethylated (“+” means digestion 
with Bsh1236I restriction enzyme, “-” means mock digestion). 
 
3.6.3 TET3 CpG-promoter methylation status 
Bisulfite pyrosequencing was applied to check the methylation pattern of 
TET3 CpG-promoters in men with low (n = 10, subfertile patients) and high (n 
= 10, healthy donors) TET3 mRNA levels (0.58 ± 0.08 (± 0.26) versus 1.41 ± 
0.12 (± 0.39), P < 0.0002, Mann–Whitney U-test; Figure 29A). After 
amplifying bisulfite-treated sperm DNA, PCR products (250 bp) were used to 
examine the methylation status of 6 CpG-positions at TET3 CpG-promoters 
(Figures 29B–D). We found that sperm TET3 CpG-promoters in the healthy 
donor group exhibiting high TET3 mRNA level, in general, were 
hypomethylated with mean methylation values of 6 CpG-sites ranging from 
1.83% to 9.33% (Figure 29E). However, the DNA methylation degrees at 
TET3 CpG-promoters in two subfertile patients were much higher up to 
37.00% and 35.50%, respectively, accompanying low TET3 mRNA 
expression (0.220 and 0.439), while the other eight patients presented 
hypomethylated TET3 CpG-promoters in sperm cells with mean methylation 
percentages ranging from 5.33% to 6.17% (Figure 29E). 
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Figure 29 Sperm TET3 CpG-promoter methylation status was measured in men 
with low (n = 10, subfertile patients) and high (n = 10, healthy donors) TET3 mRNA 
expression using bisulfite pyrosequencing. (A) Comparison of TET3-mRNA level in 
sperm cells between the selected healthy donor group and subfertile patient group 
(relative mean values ± SEM, P-values of Mann–Whitney U-test, and number of 
analyzed samples are given). (B) A schematic overview of TET3 CpG-promoter and the 
E
Characteristics CpG-P1 CpG-P2 CpG-P3 CpG-P4 CpG-P5 CpG-P6 Mean 
Donor 1 2% 4% 3% 1% 1% 2% 2.17%
Donor 2 1% 4% 3% 2% 1% 3% 2.33%
Donor 3 1% 5% 4% 1% 1% 1% 2.17%
Donor 4 3% 3% 3% 2% 0% 0% 1.83%
Donor 5 3% 3% 13% 13% 3% 3% 6.33%
Donor 6 4% 3% 8% 10% 4% 4% 5.50%
Donor 7 3% 6% 10% 14% 3% 4% 6.67%
Donor 8 6% 6% 16% 20% 4% 4% 9.33%
Donor 9 4% 7% 13% 16% 0% 8% 8.00%
Donor 10 4% 3% 13% 14% 3% 6% 7.17%
Patient 1 1% 2% 11% 12% 3% 4% 5.50%
Patient 2 1% 2% 12% 13% 3% 3% 5.67%
Patient 3 41% 32% 47% 46% 17% 39% 37.00%
Patient 4 39% 31% 46% 45% 16% 36% 35.50%
Patient 5 1% 3% 11% 11% 3% 3% 5.33%
Patient 6 1% 2% 12% 13% 2% 4% 5.67%
Patient 7 0% 2% 11% 12% 3% 4% 5.33%
Patient 8 1% 2% 12% 14% 3% 2% 5.67%
Patient 9 1% 2% 11% 13% 3% 3% 5.50%
Patient 10 2% 3% 13% 13% 3% 3% 6.17%
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selected assay containing 6 CpG-sites (brown line: CpG-island in the nucleotide strand, 
yellow line: selected assay for bisulfite pyrosequencing). (C–D) Amplified PCR products 
(250 bp) of bisulfite-treated sperm DNA from the selected healthy donors and subfertile 
patients were shown on a 2% agarose gel. (E) Results of 6 CpG-positions (CpG-P1 to 
CpG-P6) methylation in sperm TET3 CpG-promoter of the selected donors and patients, 
TET3 CpG-promoters in donor group were generally hypomethylated, while the mean 
methylation values in two subfertile patients were much higher up to 37.00% and 35.50% 
presenting low TET3-mRNA expression (0.220 and 0.439). 
 
3.7 Associations of TET1–3, DNMT1 and DNMT3A mRNA expression 
with the methylation status of the imprinted gene H19 
In this part, we aimed to underscore the impact of disturbed 
spermatogenesis on the risk of producing gametes with genomic imprinting 
defects, and investigate the influences of TET1–3, DNMT1 and DNMT3A 
mRNA expressions on the methylation pattern of the paternal imprinted gene 
H19. The imprinted gene H19 was selected, which was completely 
methylated in the paternal allele and unmethylated in the maternal allele. The 
imprinting signatures of sperm from 18 healthy donors and 20 subfertile 
patients were studied using bisulfite modification and COBRA analysis. 
After amplifying bisulfite-treated sperm DNA, PCR products (239 bp) 
were used to check the methylation status of the imprinted gene H19 with 3 
restriction recognition sits (CG..CG) digested by Bsh1236I restriction enzyme 
(Figure 30A). Applying COBRA, we found that only one healthy donor (1/18 = 
5.56%) showed aberrant methylation status at the H19 gene 
(Don-Ab-Me-H19, partially methylation), while the other 17 donors presented 
normal methylation status at the H19 gene (Don-N-Me-H19, fully methylation; 
Figure 30B and Figure 31). On the other hand, we separated subfertile men 
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suffering from oligozoospermia and/or asthenozoospermia in the “O + A” 
group (n = 16) and patients exhibiting normozoospermia in the “NZS” group 
(n = 4). Our data indicated that subfertile patients with the aberrant 
methylation of the H19 gene (Pat-Ab-Me-H19; 7/20 = 35%) included one 
“NZS” patient (1/4 = 25%), two “O + A” patients with a sperm count above 10 
Mil/ml (2/8 = 25%) and four “O + A” patients with a sperm count below 10 
Mil/ml (4/8 = 50%; Figure 30C and Figure 31). Among these seven subfertile 
patients carrying aberrant methylation at the imprinted gene H19, five of them 
(5/7 = 71.43%) suffered from low FR (< 70%), whereas four female partners 
(4/7 = 57.14%) were pregnant after ICSI treatment. 
Considering TET1–3, DNMT1 and DNMT3A mRNA expression, the only 
single donor with aberrant methylation of the H19 gene had normal TET1–3 
mRNA levels, but DNMT1 (0.630 versus 0.950) and DNMT3A (1.597 versus 
2.669) were much lower in comparison with the mean of relative mRNA levels 
in the Don-N-Me-H19 group (Figure 31). Furthermore, regarding the patient 
group, although mean of TET1–3 and DNMT1 mRNA levels was the lowest in 
the Pat-Ab-Me-H19 group, no statistical differences were found compared to 
the men of Pat-N-Me-H19 (TET1: 0.62 ± 0.15 (± 0.40) versus 0.66 ± 0.12 (± 
0.44), P = 1.000; TET2: 0.99 ± 0.43 (± 1.13) versus 1.13 ± 0.28 (± 1.01), P = 
0.579; TET3: 0.85 ± 0.19 (± 0.52) versus 1.00 ± 0.12 (± 0.45), P = 0.526 and 
DNMT1: 0.72 ± 0.29 (± 0.78) versus 0.84 ± 0.17 (± 0.60), P = 0.322; 
Mann–Whitney U-test; Figures 32A–B). Interestingly, relative DNMT3A mRNA 
level was the lowest in the Pat-Ab-Me-H19 group compared to the men of 
Pat-N-Me-H19 (0.50 ± 0.13 (± 0.34) versus 1.38 ± 0.31 (± 1.13), P = 0.047) 
and Don-N-Me-H19 (0.50 ± 0.13 (± 0.34) versus 2.73 ± 0.48 (± 1.99), P = 
0.002, Mann–Whitney U-test; Figure 32B). Finally, the changes of mRNA 
levels were shown by a color gradient intensity scale. It seemed that men in 
the Pat-Ab-Me-H19 group would more frequently exhibit low TET1–3, DNMT1 
and DNMT3A mRNA levels simultaneously (Figure 31). 
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Figure 30 Methylation status of the imprinted gene H19 in sperm cells from healthy 
donors (n = 18) and subfertile patients (n = 20) using bisulfite modification and 
COBRA analysis. (A) A schematic overview of the methylation pattern of the H19 gene 
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and the selected assay containing 3 CG..CG restriction recognition sites (brown line: 
CpG-island in the nucleotide strand, yellow line: selected assay for bisulfite 
pyrosequencing). (B) Only one healthy donor had aberrant methylation of the H19 gene 
highlighted by a red box (1/18, partially methylation), while the other 17 donors 
presented normal methylation (fully methylation). (C) The imprinted gene H19 was 
aberrantly methylated in 7 subfertile patients highlighted by red boxes (“+” means 
digestion with Bsh1236I restriction enzyme, “-” means mock digestion). 
 
Figure 31 Overview of TET1–3, DNMT1 and DNMT3A mRNA expressions in donors 
(n = 18) and patients (n = 20) with normal and aberrant methylation status at the 
Characteristics TET1 TET2 TET3 DNMT1 DNMT3A
Don-N-Me-H19
(Mean, n=17)
Don-Ab-Me-H19  (n=1) 2.237 1.249 3.531 0.630 1.597
Pat-N-Me-H19 (n=13)
1. NZS 0.744 1.776 1.152 0.228 0.210
2. NZS 0.503 1.132 1.056 0.350 1.717
3. NZS 0.767 1.169 0.686 0.425 0.532
4. O+A (≥ 10 Mil/ml) 0.683 0.017 1.361 0.243 0.335
5. O+A (≥ 10 Mil/ml) 1.070 1.624 1.353 0.646 0.992
6. O+A (≥ 10 Mil/ml) 1.668 0.660 1.387 0.747 2.687
7. O+A (≥ 10 Mil/ml) 0.236 1.591 0.515 0.681 3.784
8. O+A (≥ 10 Mil/ml) 0.292 3.901 0.675 0.683 1.072
9. O+A (≥ 10 Mil/ml) 0.276 1.032 1.940 0.744 1.843
10. O+A (< 10 Mil/ml) 1.098 0.787 0.849 1.090 0.546
11. O+A (< 10 Mil/ml) 0.252 0.726 0.232 1.871 2.919
12. O+A (< 10 Mil/ml) 0.816 0.013 0.897 2.228 0.736
13. O+A (< 10 Mil/ml) 0.154 0.271 0.833 0.959 0.577
Pat-Ab-Me-H19 (n=7)
1. NZS 0.891 0.783 0.390 0.046 0.130
2. O+A (≥ 10 Mil/ml) 0.273 0.496 1.149 1.383 0.154
3. O+A (≥ 10 Mil/ml) 1.397 2.961 0.895 0.243 0.404
4. O+A (< 10 Mil/ml) 0.493 2.166 1.175 2.156 0.904
5. O+A (< 10 Mil/ml) 0.360 0.436 0.220 0.534 0.723
6. O+A (< 10 Mil/ml) 0.573 0.080 0.439 0.626 0.905
7. O+A (< 10 Mil/ml) 0.331 0.015 1.653 0.082 0.287
1.488 1.083 2.755 0.950 2.669
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imprinted gene H19. One donor with aberrant methylation of the H19 gene 
(Don-Ab-Me-H19, n = 1) presented high TET1–3 mRNA levels, but lower DNMT1 and 
DNMT3A compared to the donors with normal methylation status (Don-N-Me-H19, n = 
17). Patients with aberrant methylation at the imprinted gene H19 (Pat-Ab-Me-H19, n = 7) 
would more frequently exhibit low TET1–3, DNMT1 and DNMT3A mRNA levels. The 
changes of mRNA expression were demonstrated by a color gradient intensity scale, as 
shown at the bottom. The deepest red color indicates a maximal decrease and the 
deepest green color indicates a maximal increase in gene expression. 
 
Figure 32 Comparisons of TET1–3, DNMT1 and DNMT3A mRNA levels among the 
donors with normal methylation pattern at the imprinted gene H19, and the 
patients exhibiting aberrant and normal methylation status. (A) Regarding TET1–3 
mRNA levels, no statistical differences were found in the patients with aberrantly 
methylated H19 gene (Pat-Ab-Me-H19, n = 7) compared to the patients with normal 
methylation status (Pat-N-Me-H19, n = 13). (B) The lowest DNMT3A mRNA level was 
found in the Pat-Ab-Me-H19 group (n = 7) compared to the men in Pat-N-Me-H19 (n = 13) 
and Don-N-Me-H19 (n = 17) groups. However, no differences of DNMT1 mRNA level 
could be observed among groups (relative mean values ± SEM, P-values of 
Mann–Whitney U-test, and number of analyzed samples are given). 
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4. DISCUSSION 
4.1 Expression of TET1–3 and 5hmC in human male germ cells 
Dynamic epigenetic changes occur during mammalian germ-cell 
development, which are regulated by a number of epigenetic modifiers 
including TETs (involved in DNA demethylation), DNMTs (responsible for DNA 
methylation), histone-modification enzymes and their regulatory factors. It is 
known that the male germ line includes two waves of global DNA 
demethylation: the first occurs in the paternal pronucleus of the 
pre-implantation embryo shortly after fertilization, and the second takes place 
during the differentiation and migration of the PGCs (Iqbal et al. 2011; Wu & 
Zhang 2011; Kohli & Zhang 2013; Gkountela et al. 2015). Previous results 
indicated that once spermatogenesis is initiated paternal imprints should have 
been already established (Hackett et al. 2013; Molaro et al. 2014; Tang et al. 
2015). DNA methylation during mammalian germ cell differentiation and the 
expression of the involved DNMTs have already been described in detail 
(Tucker et al. 1996; Kierszenbaum 2002; Yaman & Grandjean 2006; 
Takashima et al. 2009; Marques et al. 2011; Yao et al. 2015), whereas the 
impact of TETs and DNA demethylation is only sparsely documented, 
especially on human spermatogenesis and male fertility. Concerning DNA 
demethylation during spermatogenesis, studies in mice and human have 
demonstrated that male gametogenesis occurs without significant changes in 
5mC, but involves a dynamic variation in 5hmC (Gan et al. 2013; Nettersheim 
et al. 2013; Hammoud et al. 2014), and emphasized herewith the impact of 
TETs on the establishment of a feature-complete sperm DNA methylation. In 
order to get more insights into this issue, in the present study, we analyzed 
the stage specific expression pattern of all TET members (TET1–3) at both 
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mRNA and protein levels, together with 5hmC, in human testis tissues 
exhibiting normal spermatogenesis, and in mature spermatozoa.  
So far, only two studies investigated TET expression during 
spermatogenesis, and both were performed solely at the mRNA level (Gan et 
al. 2013; Nettersheim et al. 2013). In one study, cDNA microarray analysis 
was used to investigate TET1–3 mRNA expression in human normal 
testicular tissues (NTTs) obtained from patients with prostate carcinoma and 
in germ cell cancer tissues (GCCs) (Nettersheim et al. 2013). Based on data 
of this study, TET1 mRNA expression was significantly elevated in 
seminomas and embryonal carcinoma tissues, whereas low expression of 
TET1 was detected in NTTs, carcinoma-in situ (CIS), teratoma and mixed 
GCCs. TET2 expression was elevated only in CIS, and both TET2 and TET3 
mRNA expressions were low in NTTs as well as in GCCs. Interestingly, a 
strong signal of 5hmC was found in spermatogonia of NTTs, and a gradual 
reduction of the 5hmC signal was observed towards germ cells located near 
the lumen of the seminiferous tubules. Moreover, all CIS tissues and the 
majority of seminomas were detected to be hypohydroxymethylated in 
comparison with non-seminomas (Nettersheim et al. 2013). Another 
genome-wide transcriptome study in eight separated consecutive types of 
germ cells in murine spermatogenesis showed that Tet1–3 mRNA expression 
presented at much higher level in the diploid germ cells compared to the 
haploid cell types, with Tet3 mRNA showing much more abundant than Tet1 
and Tet2 mRNAs (Gan et al. 2013). Authors concluded that Tet3 may 
represent a key enzyme for the production of 5hmC from 5mC in male germ 
cells, as is the case in mouse oocytes and zygotes (Gu et al. 2011; Sakashita 
et al. 2014). Using high-throughput sequencing, they also profiled a 
genome-wide 5hmC distribution in eight continuous germ cell types and 
observed elevated 5hmC level in spermatogonia, which was then decreased 
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towards round spermatids and increased again in elongating spermatids and 
mature spermatozoa (Gan et al. 2013).  
In this study, we purposed to reveal the comprehensive profiles of 
TET1–3 mRNA and protein expression in normal human spermatogenesis 
through ISH and IHC. Our results indicated that TET1–3 expressions follow a 
specific pattern. Specifically, the three TET-mRNAs simultaneously start to 
appear in early pachytene spermatocytes in stage I, and are still detectable in 
late pachytene spermatocytes in stage V. Interestingly, TET1–3 proteins 
could be successively detected at different stages. TET2-protein could be first 
observed in the cytoplasm of the late pachytene spermatocytes exclusively in 
stage V, followed by TET1 and TET3 beginning in the nuclei of steps 1 and 3 
round spermatids, respectively. Expression of both ended in step 4 elongating 
spermatids. On the other hand, 5hmC was detected exclusively in step 5 
elongated spermatids of stage V. This finding suggests that an active DNA 
demethylation pathway may occur with the involvement of the TET enzymes 
during human spermiogenesis. We did not observe any 5hmC signal in 
spermatogonia as previously has been reported in human testis tissue 
(Nettersheim et al. 2013). Since we did not detect TET1–3 expression in 
spermatogonia as well, we supposed a passive DNA demethylation. 
Nevertheless, technical differences (e.g. tissue fixation procedures, used 
antibodies), but also the various amount of 5hmC during passive and active 
DNA demethylation, might lead to different observations. The localization of 
TET2 protein in the cytoplasm of pachytene spermatocytes was surprising as 
TET2 protein is normally regarded as a nuclear protein with the ability of DNA 
demethylation in, e.g. embryonic stem cells, hematopoietic stem cells and 
lymphomagenesis (Ko et al. 2011; Koh et al. 2011; Li et al. 2011; Quivoron et 
al. 2011; Vincent et al. 2013). However, as has been demonstrated in recent 
studies, TET2 protein may also show a cytoplasmic localization, e.g. in 
neurons involved in the regulation of cell survival (Mi et al. 2015), in colorectal 
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cancer cells in association with metastasis (Huang et al. 2016), and in human 
embryonic kidney 293T (HEK293T) cells (Chang et al. 2014; Fu et al. 2014). 
Multiple studies recently reported the existence of 5hmC in both mammalian 
DNA and RNA, and Tet enzymes also possess the activity of catalyzing the 
formation of 5hmC in RNA (Fu et al. 2014; Delatte et al. 2016; Zhang et al. 
2016). Furthermore, Delatte and coworkers found that RNA 
hydroxymethylation can affect mRNA translation, and Tet-deficient fruitflies 
suffer from impaired brain development accompanied with highly decreased 
RNA hydroxymethylation (Delatte et al. 2016). These results let us 
hypothesize that the cytoplasmic TET2 protein in human pachytene 
spermatocytes probably has the ability of regulating mRNA translation. Our 
IHC results revealed a negative staining for TET1–3 protein in elongated 
spermatids, which might be due to an antigen masking since these final germ 
cell stages are known to exhibit highly condensed chromatin. For that reason, 
it was barely possible to determine the exact translational stop points for TET 
proteins in human spermatogenesis. However, our WB and ICC analyses 
demonstrated that TET1–3 proteins were all present in human mature 
spermatozoa, while the localization of TET1–3 proteins could be attributed to 
the nuclei, when mature spermatozoa were treated with chromatin 
decondensation buffer. 
 
4.2 TET1–3, DNMT1 and DNMT3A mRNA levels in mature spermatozoa 
are significantly reduced in subfertile men 
The establishment of methylation in germ cells is a unique process and is 
essential for proper sperm production. Using both single-gene and 
genome-wide analyses, several studies reported close associations of 
abnormal DNA methylation with certain aberrant repetitive elements and 
imprinted genes, especially in sperm cells from subfertile patients with poor 
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semen quality (Houshdaran et al. 2007; Kobayashi et al. 2007; Marques et al. 
2008; Khazamipour et al. 2009; Hammoud et al. 2010; Minor et al. 2011; Li et 
al. 2013; Urdinguio et al. 2015). Furthermore, the outcome of ART treatment 
was generally poor when using the sperm presenting aberrant DNA 
methylation patterns (Kobayashi et al. 2007; Marques et al. 2008).  
Concerning DNA methylation, DNMT1 mainly ensures DNA methylation 
maintenance, while DNMT3A, 3B, and 3L are specifically responsible for the 
process of de novo DNA methylation (Carrell & Hammoud 2010; Carrell 2012; 
Boissonnas et al. 2013). The direct evidence using Dnmt3a and Dnmt3L 
knock-out mice demonstrated that lack of these enzymes could result in 
multiple serious spermatogenic defects including arrest at pachytene 
spermatocytes, imprinting failure, derepression of retrotransposons and even 
impaired chromosome synapsis  (Bourc'his & Bestor 2004; Kaneda et al. 
2004; Webster et al. 2005; Hata et al. 2006). A recent study characterized 
DNMTs expression in human normal spermatogenesis by isolating all kinds of 
spermatogenic cells from testicular biopsies through micromanipulation 
(Marques et al. 2011). They found that DNMT1, DNMT3A and DNMT3B 
mRNAs were constantly detectable at a high level from spermatogonia to 
round spermatids using RT-qPCR. Nevertheless, DNMT3L mRNA could not 
be detected in any germ cell stages but in whole testicular tissue probably 
due to low mRNA synthesis (Marques et al. 2011). Interestingly, in purified 
mature spermatozoa DNMT3B mRNA expression was absent but DNMT1 
and DNMT3A mRNAs were highly expressed probably revealing a 
post-testicular upregulation of DNMT1 and DNMT3A, which were consistent 
with our results. In contrast, immunostaining showed that DNMT1, DNMT3A 
and DNMT3B proteins were all detectable in different germ cell stages 
(Marques et al. 2011). Another research group applying ISH and IHC 
methods got a similar result that DNMT1 mRNA was expressed in 
spermatogonia, pachytene spermatocytes and round spermatids in human 
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normal spermatogenesis, whereas DNMT1 protein was absent in pachytene 
spermatocytes with an appearance in the nuclei of spermatogonia and in the 
cytoplasm of round spermatids (Omisanjo et al. 2007). Interestingly, in 
impaired spermatogenesis exhibiting round spermatids maturation arrest, it 
showed an absence of DNMT1 protein in round spermatids but a precocious 
appearance of DNMT1 protein was detected in the nuclei of pachytene 
spermatocytes, which might contribute to the failure of round spermatids to 
differentiate into elongating spermatids (Omisanjo et al. 2007). 
On the other hand, regarding DNA demethylation in male germ cells, 
apart from our findings that TET enzymes and 5hmC are successively 
expressed during human spermatogenesis, several functional studies using 
knock-out mice and murine ESCs also revealed a close association of Tet1 
and Tet2 depletion with an abnormal 5hmC level both genome-wide and at 
specific genome regions, such as gene promoters, imprinting loci and 
repetitive sequences, (Dawlaty et al. 2011; Dawlaty et al. 2013; Vincent et al. 
2013; Dawlaty et al. 2014; Huang et al. 2014). In contrast to Tet1 and Tet2 
proteins, Tet3 enzyme is mainly expressed in various types of male and 
female germ cells (Dawlaty et al. 2013; Gan et al. 2013; Gkountela et al. 
2015). Recently, 5hmC was also shown to mark the sites of DNA damage and 
promote the stability of genome (Kafer et al., 2016). Mature spermatozoa are 
transcriptionally inactive cells. Nevertheless, they might still contain 
non-degraded mRNAs from the spermatogenesis program, and thereby could 
provide the evidences of transcriptional levels of DNMTs and TETs during 
mammalian spermatogenesis.  
Based on the previous findings that DNMT1, DNMT3A and TET1–3 
mRNAs were closely related to human spermatogenesis, and were all 
expressed in purified ejaculated sperm cells, we aimed to perform several 
descriptive analyses by measuring and comparing the mRNA levels of these 
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cytosine modifying enzymes in ejaculated spermatozoa of fertile donors and 
subfertile patients who underwent ICSI-treatment with their female partners. 
In general, we found that the relative levels of DNMT1, DNMT3A, TET1 and 
TET3 mRNAs in mature sperm cells of fertile men were markedly higher than 
in subfertile patients, and they were negatively correlated with male age. 
Age-associated sperm DNA methylation alterations have been recently 
reviewed in the context of the whole sperm epigenome (Jenkins et al. 2014; 
Jenkins et al. 2015). Our data is consistent with this finding and indicates that 
the mRNA expression of these vital DNA methylation regulating enzymes is 
also dramatically decreased as male age is increasing. Concerning the 
correlations with routine semen parameters, they seem to be also linked with 
sperm production and semen quality, with close associations with sperm 
concentration (TET1–3 and DNMT3A), progressive motility (TET1, TET3 and 
DNMT3A), total motility (TET1) and normal morphology (TET1, DNMT1 and 
DNMT3A). As the coefficients of correlation in the present study are relatively 
low, further studies on a large cohort are necessary to strengthen these 
findings. Finally, we found that patients suffering from oligo- and 
asthenozoospermia, and also normoozoospermic subfertile patients, showed 
significantly decreased DNMT1, DNMT3A and TET1–3 mRNA expressions in 
mature spermatozoa. Through a genome-wide or a single-gene manner, 
several studies have already identified multiple aberrant alterations of sperm 
DNA methylation not only at broad specific loci, but also at certain imprinted 
genes and repetitive sequences in patients with idiopathic male infertility and 
normoozoospermic patients with unexplained male infertility (Poplinski et al. 
2010; Wu et al. 2010; Urdinguio et al. 2015). Therefore, our findings indicated 
that aberrant transcription of DNA-methylation governing enzymes (DNMT1, 
DNMT3A and TET1–3) could probably provide a research direction to 
elucidate the aberrant DNA methylation patterns of ejaculated sperm cells in 
men with idiopathic and unexplained male infertility. 
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4.3 TET2 and TET3 mRNAs in mature sperm cells are significantly 
associated with the ICSI outcome 
Global dynamic modification of cytosine, namely DNA methylation and 
demethylation, has been observed during both pre- and post-implantation 
embryonic development (Okano et al. 1999; Hirasawa et al. 2008; Gu et al. 
2011; Wossidlo et al. 2011; Saitou et al. 2012; Kohli & Zhang 2013). 
Therefore, understanding the distinctive epigenetic modifications, which are 
adjusted by reprogramming during embryo development, has important 
implications for the outcome of ART treatment. It is now generally accepted 
that sperm contributes not only the paternal genome, but also epigenetic 
signatures to the oocytes. Although the oocyte is able to repair aberrant 
sperm DNA methylation, its capacity is limited (Wossidlo et al. 2010). Using 
immunostaining for DNA methylation, one study linked the global status of 
sperm DNA methylation to the pregnancy rate, associating methylation 
defects with embryo development and infertility (Benchaib et al. 2005). Sperm 
cells from oligozoospermic patients have more chances of carrying aberrant 
DNA methylation patterns and, therefore, a higher risk of transmitting 
incorrect primary imprints to their offspring. Furthermore, the outcome of ART 
was generally poor (Kobayashi et al. 2007; Marques et al. 2008). We 
therefore purposed to analyze the associations of mRNA expression of DNA 
methylation governing enzymes including DNMT1, DNMT3A and TET1–3, 
which were detected and measured by RT-qPCR in ejaculated sperm cells, 
with ICSI outcome including fertilization rate (FR) and pregnancy status. 
It is known that DNMT1 and DNMT3A enzymes are essential for DNA 
methylation maintenance and re-establishment of de novo methylation during 
embryonic development, respectively (Okano et al. 1999; Howell et al. 2001; 
Kaneda et al. 2004; Hirasawa et al. 2008). Conditional knockout of maternal 
and zygotic Dnmt1 will lead to a complete DNA demethylation at imprinted 
genes in mouse blastocyst (Hirasawa et al. 2008). Several studies showed 
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that Dnmt1 protein was expressed in the cortical cytoplasm using 
immunostaining (Howell et al. 2001; Ratnam et al. 2002; Hirasawa et al. 2008; 
Gu et al. 2011). However, Dnmt1 protein could also be detected in the nuclei 
of pre-implantation embryos, which was at a low level, but sufficient to 
maintain DNA methylation of imprinted genes (Hirasawa et al. 2008). A recent 
study also demonstrated that human DNMT1 protein was expressed in both 
oocytes and zygotes, which was localized in the cytoplasm and in the 
pronuclei as well (Petrussa et al. 2014). However, concerning the paternal 
effect, our data indicated that decreased level of DNMT1 in human mature 
sperm cells had no influence on fertilization rate and pregnancy, probably 
because maternal (oocyte) DNMT1 protein was already enough for the 
maintenance of DNA methylation during pre-implantation development. In 
comparison with Dnmt1, Dnmt3a was mainly observed in male and female 
pronuclei of mouse zygotes showing dispensable for the maintenance of DNA 
methylation in the pre-implantation stages (Hirasawa et al. 2008), but 
indispensable for de novo methylation after implantation (Okano et al. 1999; 
Kaneda et al. 2004). Interestingly, Dnmt3a knockout mouse embryos can 
develop to term, but die shortly after birth, with loss of genomic imprinting 
signatures in germ cells, indicating that absence of Dnmt3a enzyme will not 
impede embryonic development (Okano et al. 1999; Kaneda et al. 2004). 
Consistent with these findings, our data showed DNMT3A mRNA level did not 
differ in terms of fertilization rate and pregnancy status. Furthermore, in 
human zygotes, different to mouse Dnmt3a protein expression, DNMT3A was 
not detectable until the morula stage (Petrussa et al. 2014). This finding leads 
to the assumption that paternal-contributed DNMT3A protein might be 
degraded in human oocytes after fertilization.  
In terms of DNA demethylation in pre-implantation embryo, compared to 
Tet1 and Tet2, Tet3 shows exclusively high levels of mRNA expression 
confined to oocytes and zygotes (Gu et al. 2011; Iqbal et al. 2011; Wossidlo 
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et al. 2011). It has been shown that maternally derived Tet3 enzyme is 
responsible for hydroxymethylation of the epigenetic reprogramming on the 
zygotic paternal genome already in the pronucleus stage (Gu et al. 2011; 
Iqbal et al. 2011). Conditional knockout of zygotic Tet3 would result in a failed 
conversion of 5mC into 5hmC and constantly elevated 5mC level in the 
paternal genome (Gu et al. 2011). Female mice depleted of Tet3 in the germ 
line exhibited severely reduced fecundity, and their Tet3-deficient oocytes 
had a reduced ability of regulating DNA hydroxymethylation to reprogram the 
injected nuclei from somatic cells (Gu et al. 2011). However, loss of maternal 
Tet3 alone would not block differentiation and embryonic development with 
the evidence that homozygous mutant Tet3 mice can develop to term but die 
shortly after birth (Gu et al. 2011), probably due to the compensational 
function of paternally derived Tet3. Our data revealed that TET3-mRNA 
expression in human sperm cells was closely related with FR. When defining 
the threshold of fertilization rate as 70% (van Golde et al. 2001; Tournaye et 
al. 2002; Palermo et al. 2009; Rogenhofer et al. 2013), subfertile patients 
whose sperm achieved high-FRs showed significantly increased TET3 in 
comparison with those with low-FRs. Therefore, this finding indirectly 
demonstrated that TET3 in sperm cells might also have the contribution of 
5hmC in fertilization. Nevertheless, TET3-mRNA showed no differences 
between the pregnancy and the non-pregnancy group in our study. Animal 
studies demonstrated that Tet3 was nearly absent in 2-cell embryos, ESCs 
and mouse embryonic fibroblasts (MEFs) (Iqbal et al. 2011; Wossidlo et al. 
2011), and germ cell-specific Tet3 depletion in mouse would not significantly 
affect DNA hydroxymethylation in post-implantation stages and early 
embryogenesis (Gu et al. 2011).  
In mice, Tet1 and Tet2 are especially involved in mediating the 
expression of pluripotency transcription factors, such as Nanog, Esrrb 
(estrogen-related receptor β) and Prdm14 (PR domain containing 14) (Ito et 
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al. 2010; Ficz et al. 2011; Koh et al. 2011; Williams et al. 2011). Conditional 
knockout of Tet1 or/and Tet2 in mouse ESCs, they remained pluripotent, but 
impaired differentiation might occur with a dramatic reduction of 5hmC, and 
lead to a development towards the extra-embryonic lineages (Ito et al. 2010; 
Ficz et al. 2011; Koh et al. 2011; Williams et al. 2011). Furthermore, Tet2 is 
extensively expressed in the mouse oocytes and embryonic development, 
such as zygotes, 2-cell embryos, ESCs and MEFs (Ito et al. 2010; Iqbal et al. 
2011; Koh et al. 2011; Wossidlo et al. 2011). Our results also demonstrated 
that men of couples, whose female partners achieved pregnancy, had a 
significantly higher level of TET2 in their sperm compared to men in the 
non-pregnant group. This finding indicated that TET2 enzyme in human 
sperm probably regulated special certain pluripotency transcription genes in 
zygotes, which might affect post-implantation embryonic development. 
However, TET2 mRNA level showed no correlation with FR in this study, 
probably due to the complementary contribution of TET3, which plays a key 
function to generate 5hmC in the mammalian zygote (Gu et al. 2011; Iqbal et 
al. 2011). On the other hand, Tet1 is exclusively detected at a high level in 
ESCs, whereas it is barely detected in oocytes and zygotes (Dawlaty et al. 
2011; Ficz et al. 2011; Iqbal et al. 2011; Koh et al. 2011; Williams et al. 2011; 
Wossidlo et al. 2011; Dawlaty et al. 2013). Our data revealed that the 
TET1-mRNA level in human sperm cells was not associated with FR and 
pregnancy. Although a fraction of the mutant embryos exhibited midgestation 
abnormalities with perinatal lethality, Tet1 knockout mice of both sexes were 
viable and fertile with a reduced size (Dawlaty et al. 2011; Dawlaty et al. 
2013). However, these mutant mice revealed aberrant methylation at various 
imprinted loci with failed conversion of 5mC into 5hmC (Dawlaty et al. 2011; 
Dawlaty et al. 2013). Overall, given the fact that we also found considerable 
amounts of non-degraded TET proteins in human sperm, we could speculate 
about the developmental impact of paternally contributed TET2 and TET3 
enzymes.  
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4.4 Aberrant methylation of TET3 CpG-promoter might down-regulate 
TET3-mRNA transcription in sperm cells 
In mammalian genomes, many genes exhibit CpG islands in their 
promoters that are associated with gene transcription. In the human genome, 
approximate 70% of gene promoters reveal a high CpG content in or near the 
promoters (Weber et al. 2007; Deaton & Bird 2011). In most instances, 
unmethylated CpG islands are associated with gene expression, while 
methylated CpG sites result in the repression of gene expression. Therefore, 
in many diseases, hypomethylation, in general, arises earlier and upregulates 
abnormal transcription, which is linked to chromosomal instability and loss of 
imprinting, whereas abnormal hypermethylation in CpG-promoters, such as in 
most cancer tissues, can result in transcriptional silencing following cell 
division (Egger et al. 2004; Dodge et al. 2005; Robertson 2005; Weber et al. 
2007; Deaton & Bird 2011). However, currently no publications have reported 
whether the methylation status at TET1–3 CpG-promoters will affect their 
mRNA synthesis. In this study, we demonstrated that low TET1–3 mRNA 
levels in mature spermatozoa were closely associated with poor spermiogram 
profiles. Moreover, TET2 and TET3 mRNA levels were linked with ICSI 
outcome. Therefore, it is valuable to elucidate the influences of TET1–3 
CpG-promoter methylation status on their corresponding mRNA transcription.  
Our results indicated that sperm TET1–2 CpG-promoters, in general, 
were unmethylated, regardless of men with low (healthy donors) and high 
(subfertile patients) mRNA expression. Nevertheless, compared to the donors 
with high TET3-mRNA level exhibiting hpyomethylated TET3 CpG-promoters 
in sperm cells, two subfertile patients with low TET3-mRNA expression 
showed partially methylated TET3 CpG-promoters in ejaculated sperm. The 
regulation of the CpG-promoter methylation status, therefore, might affect 
TET3-mRNA expression, but not TET1 and TET2. Interestingly, consistent 
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with our previous results that sperm TET3-mRNA level was associated with 
fertilization but not pregnancy, the fertilization rates of these two patients, who 
also suffered from severe oligozoospermia with a sperm count below 10 
Mil/ml, were both below 70%, but one female partner was pregnant after ICSI 
treatment. Furthermore, they also had aberrant methylation at the H19 
imprinted gene based on COBRA results. This finding was in line with several 
studies reporting that aberrant methylation at the imprinted gene H19 was 
frequently observed in subfertile patients with severe oligospermia (Kerjean 
et al. 2000; Marques et al. 2004; Kobayashi et al. 2007; Marques et al. 2008). 
Nevertheless, because of the limited material in this study, there is a need for 
a larger cohort study. Although TETs are known to adjust other mRNAs 
synthesis (Wu et al. 2011; Pastor et al. 2013), further studies are required to 
investigate the mechanisms of TET-mRNA transcriptional regulation.  
In conclusion, these findings led to the hypothesis that severely 
oligozoospermic patients not only carried abnormal methylated imprinted 
gene, but also suffered from aberrantly partially methylated TET3 
CpG-promoter in sperm cells, which might down-regulate sperm TET3-mRNA 
transcription and further impede fertilization during ICSI procedure. 
 
4.5 DNA methylation governing enzymes might be associated with the 
methylation pattern of the imprinted gene H19 in sperm cells 
Since the first report of successful pregnancy achieved by ICSI (Palermo 
et al. 1992), this technique has become the most common method of choice 
for infertile patients at reproductive age, especially for male factor infertility. 
However, because of neglecting the natural elimination of defective 
spermatozoa during ICSI procedure, it may account for a higher risk of 
transmitting incorrect genomic information to the offspring resulting in 
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aberrant embryo cell divisions, congenital malformations and hereditary 
disorders (Johnson 1998; Wennerholm et al. 2000; Ericson & Kallen 2001; 
Devroey & Van Steirteghem 2004). Indeed, various clinical studies reported 
an increased incidence of rare imprinting deregulation in children conceived 
with ART, such as Beckwith–Wiedemann syndrome (BWS; 11p15) (DeBaun 
et al. 2003; Maher et al. 2003) and Angelman syndrome (AS; 15q11-q13) 
(Clayton-Smith & Laan 2003; Ludwig et al. 2005).  
Genomic imprinting is an epigenetic phenomenon involving DNA 
methylation without altering the genetic sequence, by which certain genes are 
expressed in a parental-of-origin dependent manner leading to allele-specific 
expression due to the different methylation status of CpG dinucleotides at 
differentially methylated regions (DMRs) (Reik & Walter 2001; Barlow & 
Bartolomei 2014). DNA methylation is a heritable epigenetic modification, 
which might represent the most valuable epigenetic information transmitted 
from sperm cells to oocytes (Steger 1999; Jones & Takai 2001). Recently, the 
high influence of sperm methylome was emphasized by the finding in 
zebrafish indicating maternal genome was reprogrammed to match the 
paternal methylation after fertilization (Jiang et al. 2013; Potok et al. 2013). 
Appropriate genomic imprinting plays an important role in embryonic 
development, placental function and neurological processes and behavior 
(Surani 1998; Tilghman 1999). Up to now, the methylation patterns of several 
imprinted genes have been well determined, H19 is one of the best 
characterized examples, which encodes for an untranslated RNA presenting 
completely methylated (repressed) in the paternal allele and fully 
unmethylated (expressed) in the maternal allele (Bartolomei et al. 1993; 
Tremblay et al. 1995). Several studies reported a close association of 
hypospermatogenesis with abnormal genomic imprinting of the H19 gene. 
Specifically, aberrant methylation patterns at the H19 gene were observed in 
oligozoospermic patients, especially for severe oligozoospermia (< 10 Mil/ml), 
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and in a small number of normozoospermic subfertile patients (Marques et al. 
2004; Kobayashi et al. 2007; Marques et al. 2008; Boissonnas et al. 2010). 
These findings were consistent with our results, as we found only one 
normozoospermic healthy donor revealing aberrantly methylated H19 gene. 
However, this man was not married and did not prepare to become a father 
via natural conception. Interestingly, one study revealed that male idiopathic 
infertility was strongly associated with aberrant methylation of the H19 gene 
(Poplinski et al. 2010). Moreover, the outcome of ART treatment using sperm 
exhibiting abnormal at DNA methylation pattern of the H19 gene was 
generally poor (Kobayashi et al. 2007). Our data were in line with this finding 
demonstrating that 71.43% (5/7) of patients carrying an aberrant methylation 
pattern at the H19 gene had low FR (< 70%), whereas 57.14% (4/7) of female 
partners were pregnant. Nevertheless, a reduced DNA methylation level 
might be also observed at the aberrant H19-DMRs in placentas from 
pregnancies (Nelissen et al. 2013). These evidences highlight the need for 
more research into the mechanisms of aberrant methylation of imprinted 
genes. Therefore, we aimed to investigate the association of DNA 
methylation governing enzymes (TET1–3, DNMT1 and DNMT3A) with the 
methylation pattern of the imprinted gene H19 in mature spermatozoa. 
In the human germ line, DNA methylation of the imprinted gene H19 
should be first erased at an early fetal stage by TET enzymes, while the 
paternal specific imprint is completely re-established through the activity of 
DNMTs during spermatogonial differentiation in the adult testis (Davis et al. 
2000; Kerjean et al. 2000; Saitou et al. 2012; Kohli & Zhang 2013). Two 
waves of genome-wide DNA demethylation regarding imprint erasure were 
reported in male germ line involved in the function of Tet1–3 enzymes (Kohli 
& Zhang 2013). In the first wave of dynamic global demethylation, Tet3 
protein mainly accounts for the unique process of imprint erasure in the 
paternal pronucleus shortly after fertilization, whereas the second wave in 
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primordial germ cells was regulated by Tet1 and Tet2 (Gu et al. 2011; Inoue & 
Zhang 2011; Li et al. 2011; Yamaguchi et al. 2012; Hackett et al. 2013). 
Currently, several studies reported the dynamics of DNA demethylation in 
human preimplantation embryos and prenatal germline shares tremendous 
similarities with those of mouse at the equivalent stages (Guo et al. 2014; 
Smith et al. 2014; Gkountela et al. 2015). Our previous results showed that 
TET1–3 proteins were also closely related to human spermatogenesis, which 
were detected in human purified sperm cells as well. Therefore, we studied 
the association of relative TET1–3 mRNA levels with the methylation status of 
the imprinted gene H19 in human mature spermatozoa. No differences were 
found between patients with Ab-Me-H19 and N-Me-H19. This finding 
indicates that TETs might not affect the methylome of postnatally imprinted 
genes in human germ line after the re-establishment of imprints, which could 
be mainly responsible for DNA demethylation of imprinted gene in prenatal 
embryonic development. 
On the other hand, human mRNA and protein expression of DNMT1 and 
DNMT3A were both detected in all stages of spermatogenic cells from 
spermatogonia to mature spermatozoa acting as a maintenance and de novo 
DNA methyltransferase respectively during replication (Omisanjo et al. 2007; 
Marques et al. 2011). Conditional knockout of Dnmt1 in the mouse model 
reveals Dnmt1 protein is responsible for genome-wide DNA methylation 
maintenance (Howell et al. 2001; Hirasawa et al. 2008). Meanwhile, a 
germline-specific gene-knockout study indicates that Dnmt3a enzyme has a 
central role for all known paternally methylated loci in the de novo methylation 
process, except for the Rasgrf1 locus, whose imprint is re-established by 
Dnmt3b (Kaneda et al. 2004; Kato et al. 2007). Our data indicated that 
severely reduced DNMT3A level in mature spermatozoa might be associated 
with aberrantly methylated H19 gene based on the evidences that DNMT3A 
mRNA level in the patients with Ab-Me-H19 was the lowest compared to the 
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subfertile patients with N-Me-H19 and the donors with N-Me-H19. However, 
relative DNMT1 mRNA level showed no differences in purified sperm cells 
among donors with N-Me-H19 and patients with N-Me-H19 and Ab-Me-H19. 
Previous observations in mouse and human showed that H19 methylation is 
completed by the mature spermatozoa stage (Kerjean et al. 2000; Li et al. 
2004). Therefore, this finding supports the hypothesis that abundant de novo 
methylation is required for the maintenance of methylation patterns after their 
establishment. Moreover, overview of individual values of mRNA levels in 
donors and patients showed multiple low TET1–3, DNMT1 and DNMT3A 
mRNA expressions were observed simultaneously in the Pat-Ab-Me-H19 
group, which led to the assumption that the comprehensive defects of DNA 
methylation governing enzymes rather than unique enzyme result in aberrant 
methylation of the imprinted genes in mature spermatozoa. Nevertheless, 
several potential limitations of this part should be considered as well. Due to 
the limited materials in this study, further studies on a large cohort are 
necessary to strengthen these findings. Furthermore, our findings were 
restricted to one specific imprinted gene H19, therefore, a multi-gene 
investigation, covering both maternally and paternally expressed imprinted 
gene should be performed.
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5. SUMMARY 
Epigenetic reprogramming during male germ cell differentiation plays a 
crucial role in regulating genome functions at critical stages of development. 
DNA methylation profiles are mainly established and maintained by DNMT 
family members, whereas TET dioxygenases are essential for active DNA 
demethylation in the paternal pronuclei and in ESCs. 
The present study focused on the expression of TET1–3 enzymes during 
human spermatogenesis and in mature spermatozoa. Furthermore, it should 
be clarified whether aberrant expression of TET1–3, DNMT1 and DNMT3A 
mRNAs are associated with aberrant imprinting of the H19 gene, male 
subfertility and poor outcome of ICSI treatment. 
During normal human spermatogenesis TET1–3 mRNAs are present in 
the cytoplasm of pachytene spermatocytes from stage I to stage V, while 
TET1–3 proteins are successively expressed: TET2 is expressed in the 
cytoplasm of late pachytene spermatocytes of stage V, then TET1 can be 
observed in the nuclei of step 1 round spermatids at stage I, and TET3 in the 
nuclei of step 3 round spermatids at stage III. 5hmC appears only in step 5 
elongated spermatids. All three TETs are still detectable at the mRNA and 
protein level in mature sperm cells in considerable amounts. 
TET1–3, DNMT1 and DNMT3A mRNA levels in spermatozoa are 
significantly reduced in subfertile patients. In addition, they are closely 
associated with male age and routine semen parameters. TET2 and TET3 
mRNA levels in mature sperm cells are significantly associated with 
pregnancy and fertilization rate after ICSI treatment, respectively. Aberrant 
methylation of TET3, but not TET1–2, CpG-promoter might down-regulate 
TET3-mRNA transcription. Finally, DNA methylation reprogramming enzymes, 
especially DNMT3A, might be associated with the methylation pattern of the 
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imprinted gene H19 in human mature spermatozoa. 
Our data provide first hints that TETs enzymes and DNA-demethylation 
are essential for male germ cell differentiation. In addition, TET1–3, DNMT1 
and DNMT3A mRNA levels in human mature spermatozoa seems to be 
important for male fertility and success of ART treatment. 
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6. ZUSAMMENFASSUNG 
Die epigenetische Reprogrammierung während der männlichen 
Keimzelldifferenzierung spielt für die Regulation der Genexpression eine 
entscheidende Rolle. Während die Methylierung der DNA vornehmlich durch 
Enzyme der DNMT-Familie etabliert und aufrecht erhalten wird, erfolgt die 
active Demethylierung der DNA im paternalen Pronukleus und in 
embryonalen Stammzellen durch TET Dioxygenasen. 
In der vorliegenden Studie wurde die Expression der TET1–3 Enzyme 
während der Spermatogenese und in ejakulierten menschlichen Spermien 
untersucht. Darüber hinaus sollte geklärt werden, ob eine aberrante 
Expression von TET1–3, DNMT1 und DNMT3A mRNA mit einem 
abnormalen Imprinting des H19 Gens bzw. männlicher Subfertilität und/oder 
dem Ergebnis einer ICSI-Behandlung assoziiert ist. 
Während der normalen Spermatogenese konnten TET1–3 mRNAs im 
Zytoplasma von pachytänen Spermatozyten (Stadium I-V) nachgewiesen 
werden, wohingegen die TET1–3 Proteine ein sukkzessives 
Expressionsmuster zeigten. So wurde TET2 im Zytoplasma von späten 
pachytänen Spermatozyten (Stadium V) exprimiert. TET1 hingegen war in 
den Zellkernen von step 1 runden Spermatiden (Stadium I) und TET3 in den 
Zellkernen von step 3 runden Spermatiden (Stadium III) nachweisbar. 5hmC 
war ausschließlich in step 5 elongierten Spermatiden (Stadium V) zu sehen. 
Alle drei TET Enzyme sind zudem sowohl auf mRNA-, als auch auf 
Protein-Ebene in ejakulierten Spermien nachzuweisen. 
In subfertilen Patienten ist die Menge an TET1–3, DNMT1 und DNMT3A 
mRNAs in Spermien significant reduziert. Darüber hinaus zeigt die 
mRNA-Menge eine Korrelation mit dem Alter des Mannes und mit 
Routine-Samenparametern. Die Menge an TET2 bzw. TET3 in Spermien ist 
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zudem significant mit der Schwangerschaftsrate bzw. Der Fertilisierungsrate 
nach ICSI korreliert. Eine abnormale Methylierung von CpG-Inseln im TET3 
Genpromoter, aber nicht in den Promotoren von TET1 und TET2, könnte 
somit die Transkription der TET3 mRNA herunter regulieren. Schließlich 
lassen unsere Ergebnisse eine Assoziation von DNMT3A mit dem 
Methylierungsmuster des paternalen Imprintinggens H19 in Spermien 
vermuten. 
Zusammenfassend lässt sich feststellen, dass die Ergebnisse dieser 
Studie erste Hinweise dafür liefern, dass TET Enzyme und 
DNA-Demethylierung eine wichtige Rolle in der männlichen 
Keimzelldifferenzierung spielen. Darüber hinaus scheint die Menge an 
TET1–3, DNMT1 und DNMT3A mRNA in Spermien einen Einfluss auf die 
männliche Fertilität bzw. den Erfolg einer ICSI-Behandlung zu haben. 
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8. SUPPLEMENTARY INFORMATION 
8.1 Chemicals 
Acetic acid Roth, Karlsruhe 
Acrylamide/Bisacrylamide (37.5:1)  Bio-Rad, Munich 
Agarose Roth, Karlsruhe 
Ammonium persulfate (APS)  Sigma-Aldrich, Steinheim 
Ampicillin Roth, Karlsruhe 
Bovine serum albumin (BSA) Roth, Karlsruhe 
Cyclohexylamino propanesulphonic acid (CAPS) Roth, Karlsruhe 
Chloroform Roth, Karlsruhe 
Citric acid Merck, Darmstadt 
Dextran sulphate sodium salt Sigma-Aldrich, Steinheim 
Diethypyrocarbonate (DEPC) Sigma-Aldrich, Steinheim 
Dithiothreitol (DTT) Roth, Karlsruhe 
Ethanol  Sigma-Aldrich, Steinheim 
Ethylenediamine tetraacetic acid (EDTA) Roth, Karlsruhe 
Formaldehyde Sigma-Aldrich, Steinheim 
Formamide Sigma-Aldrich, Steinheim 
Glycerol Roth, Karlsruhe 
Glycin Roth, Karlsruhe 
Glycogen Invitrogen, Karlsruhe 
Hydrogen chloride (HCl), 2 N   Roth, Karlsruhe 
Isopropanol Sigma-Aldrich, Steinheim 
LB medium Roth, Karlsruhe 
Levamisole Sigma-Aldrich, Steinheim 
Lithium 3,5-diiodosalicylate Sigma-Aldrich, Steinheim 
Lithium chloride (LiCl) Roth, Karlsruhe 
Magnesium chloride (MgCl2) Merck, Darmstadt 
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Methanol Sigma-Aldrich, Steinheim 
β-Mercaptoethanol AppliChem, Darmstadt 
N,N,N',N'-Tetramethylethylenediamine (TEMED) Roth, Karlsruhe 
Non-fat dry milk Roth, Karlsruhe 
Orange G Merck, Darmstadt 
Paraformaldehyde (PFA) Merck, Darmstadt 
Phenol/chloroform Roth, Karlsruhe 
Phenylmethylsulfonylfluorid (PMSF) Roth, Karlsruhe 
Phosphate buffered saline (PBS)  Sigma-Aldrich, Steinheim 
Ponceau S solution Sigma-Aldrich, Steinheim 
Protease inhibitor cocktail tablets Sigma-Aldrich, Steinheim 
Roti®-Phenol Roth, Karlsruhe 
Sodium dodecyl sulfate (SDS) solution, 10% (W/V) Bio-Rad, Munich 
sodium acetate (NaOAc) Roth, Karlsruhe 
Sodium chloride (NaCl) Roth, Karlsruhe 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe 
Tris-base Roth, Karlsruhe 
Tris-HCl Roth, Karlsruhe 
Tri-sodium citrate Merck, Darmstadt 
Triton X-100 Sigma-Aldrich, Steinheim 
Tween-20 Roth, Karlsruhe 
Xylol VWR, Darmstadt 
 
8.2 Reagents and buffers 
8.2.1 Cell culture 
Dulbecco's Modified Eagle Medium (DMEM)  Life Technologies, Darmstadt 
Dulbecco's PBS (1×) w/o Ca2+ & Mg2+ Gibco, Darmstadt 
Fetal calf serum Biochrom AG, Berlin 
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Penicillin/Streptomycin Gibco, Darmstadt 
RPMI 1640 medium  Life Technologies, Darmstadt 
Synth-a-Freeze cryopreservation  Gibco, Darmstadt 
TrypLE™ Express reagent  Gibco, Darmstadt 
 
8.2.2 IHC, ICC and IF 
DAB enhanced liquid substrate system Sigma-Aldrich, St. Louis 
SIGMAFAST Fast Red Sigma-Aldrich, St. Louis 
Vectashield® Mounting Medium with DAPI Vector, Burlingame 
VECTASTAIN Elite ABC-AP system Vector, Peterborough 
VECTASTAIN Elite ABC-Peroxidase system Vector, Peterboroug 
PBS buffer (0.01 M), pH 7.4: 1 PBS tablet in 200 ml deionized water. 
2% Triton/PBS buffer, pH 7.4: 2 ml Triton X-100 in 98 ml PBS buffer. 
3% BSA buffer: 3 g BSA in 100 ml 2% Triton/PBS buffer. 
10 × Tris-HCl buffer, pH 7.4: 121.1 g Tris-HCl and 58.4 g NaCl in 1 l 
deionized water. 
Citrate buffer, pH 6.0: 18 ml stock solution A (21.01 g citric acid, 1 l 
deionized water), 82 ml stock solution B (29.41 g tri-sodium citrate, 1 l 
deionized water) and 900 ml deionized water. 
 
8.2.3 WB  
Coomassie stain ROTH, Karlsruhe 
Laemmli sample buffer (4×) Bio-Rad, Munich 
Pierce BCA Protein Assay Kit Thermo Scientific, Waltham 
Pierce ECL Western blotting substrate Thermo Scientific, Waltham 
Protein size markers Life Technologies, Darmstadt 
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Lysis buffer for protein extraction, pH 7.4: 10 mM Tris-HCl, 150 mM NaCl, 
1 mM EDTA, 1 mM DTT, 1 mM PMSF, 1 × Protease inhibitor cocktail and 1% 
Triton X-100.  
30% Acrylamide solution: Acrylamide/Bisacrylamide = 37.5:1. 
10% APS: 50 mg APS in 500 µl deionized water. 
7.5% separating gel: 4.85 ml water, 2.5 ml 1.5 M Tris-HCl (pH 8.8), 100 µl 
10% SDS, 2.5 ml 30% Acrylamide, 50 µl 10% APS and 25 µl TEMED. 
4% stacking gel: 3 ml water, 1.25 ml 0.5 M Tris-HCl (pH 6.8), 50 µl 10% SDS, 
0.65 ml 30% Acrylamide, 25 µl 10% APS and 12.5 µl TEMED. 
Laemmli loading buffer: 90 µl Laemmli sample buffer (4×) and 10 µl 
β-mercaptoethanol.  
10 × Electrophoresis buffer, pH 8.3: 30.3 g Tris-base, 144 g Glycin and 10 
g SDS in 1 l deionized water.  
10 × Tris/CAPS buffer, pH 9.6: 25 g CAPS and 20.5 g Tris-base in 282.5 ml 
deionized water. 
Cathode buffer: 0.75 ml 10% SDS and 74.25 ml 1 × Tris/CAPS buffer. 
Anode buffer: 7.5 ml methanol and 42.5 ml 1 × Tris/CAPS buffer. 
10 × Tris buffered saline (TBS), pH 7.4: 24.2 g Tris-base and 80 g NaCl in 1 
l deionized water. 
1 × TBS/T washing buffer: 50 µl Tween-20 in 100 ml 1 × TBS buffer. 
Blocking buffer, pH 7.4: 5 g non-fat dry milk in 100 ml 1 × TBS/T buffer. 
 
8.2.4 ISH 
Denhardt’s solution (50×) Sigma-Aldrich, Steinheim 
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Digoxigenin (DIG) RNA Labeling Kit (SP6/T7) Roche, Mannheim 
NBT/BCIP reagent KPL, Gaithersburg 
NucleoSpin Gel and PCR clean-up kit Macherey Nagel, Düren 
pGEM-T Vector Promega, Mannheim 
QIAfilter Plasmid Midi Kit Qiagen, Hilden 
QIAprep Spin Miniprep Kit Qiagen, Hilden 
Salmon sperm DNA Thermo Scientific, Waltham 
E. coli XL1-Blue strain competent cells Stratagene, Heidelberg 
Yeast t-RNA  Thermo Scientific, Waltham 
LB/Ampicillin medium: 20 g LB medium and 1660 µl Ampicillin (60 mg/ml) 
in 1 l double distilled water.  
PBSM buffer, pH 7.4: 5 mM MgCl2 in 0.01 M PBS in DEPC water. 
Proteinase K (20 mg/ml): 40 mg Proteinase K in 2 ml PBSM buffer. 
20 × SSC buffer, pH 7.0: 88.23 g sodium citrate and 175.29 g NaCl in 1 l 
DEPC water. 
Hybridization buffer: 50% deionized formamide, 10% dextran sulphate, 2 × 
SSC, 1 × Denhardt’s solution, 10 µg/ml salmon sperm DNA and 10 µg/ml 
yeast t-RNA. 
1 × TNMT buffer, pH 7.5: 100 mM Tris-HCl, 150 mM NaCl, 4.38 mM MgCl2 
and 0.5% Triton X-100 in DEPC water. 
1 × NTB buffer, pH 9.6: 150 mM NaCl, 100 mM Tris-HCl and 50 mM MgCl2 
in DEPC water. 
 
8.2.5 PCR 
DNase I, RNase-free Thermo Scientific, Waltham 
dNTP Mix Promega, Mannheim 
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EDTA (0.5 M), pH 8.0 Thermo Scientific, Waltham 
iScriptTM cDNA Synthesis kit Bio-Rad, Munich 
GelRed Nucleic Acid Gel Stain Biotium, Fremont 
GeneRuler DNA Ladder Mix Thermo Scientific, Waltham 
M-MLV Reverse Transcriptase Promega, Mannheim 
MyTaq™ mix Bioline, Taunton 
Oligo dT Promega, Mannheim 
PeqGOLD TriFast VWR, Erlangen 
RNase inhibitor Promega, Mannheim 
Rotor-Gene SYBR Green PCR kit Qiagen, Hilden 
RNeasy Plus Micro and Mini Kits Qiagen, Hilden 
6 × DNA loading buffer with Orange G: 1% (w/v) Orange G, 40% sucrose 
10 × TAE buffer, pH 8.0: 48.4 g Tris base, 11.42 ml Glacial acetic acid, 20 ml 
0.5 M EDTA in deionized water up to 1l 
2% agarose gel: 1.8 g Agarose, 100 ml 1× TAE-Puffer 
 
8.2.6 COBRA and Bisulfite pyrosequencing 
EpiMark® Bisulfite Conversion Kit  New England Biolabs, Ipswich 
PyroMark Annealing Buffer Qiagen, Hilden 
PyroMark Binding Buffer Qiagen, Hilden 
PyroMark Denaturation Solution Qiagen, Hilden 
PyroMark Gold Q24 Reagents Qiagen, Hilden 
PyroMark Wash Buffer Qiagen, Hilden 
Streptavidin-coated Sepharose beads GE Healthcare, Freiburg 
Lysis buffer for DNA extraction, pH 8.0: 10 mM Tris-HCl, 150 mM NaCl, 1 
mM EDTA, 0.5% SDS, 1 mM DTT and 1.5 mg/ml proteinase K. 
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8.3 Enzymes 
Bsh1236I (BstUI) (10 U/µl) Thermo Scientific, Waltham ER0922 
CpG methyltransferase (M.SssI) Thermo Scientific, Waltham EM0821 
DNase I, RNase-free (1U/ul) Thermo Scientific, Waltham EN0525 
NcoI (10 U/µl) Thermo Scientific, Waltham ER0575 
NotI (10 U/µl) Thermo Scientific, Waltham ER0595 
Proteinase K Roth, Karlsruhe 7528.2 
 
8.4 Antibodies 
Primary antibodies 
Rabbit anti TET1 GeneTex, San Antonio GTX124207 
1: 400 (IHC) 
1: 2000 (WB) 
Rabbit anti TET2 Abcam, Cambridge ab94580 1: 400 (IHC) 
Rabbit anti TET2 GeneTex, San Antonio GTX124205 1: 1000 (WB) 
Rabbit anti TET3 Novus, Littleton NBP2-13427 1: 400 (IHC) 
Rabbit anti TET3 GeneTex, San Antonio GTX121453 1: 1000 (WB) 
Rat anti 5hmC Abcam, Cambridge ab106918 1: 300 (IF) 
Secondary antibodies 
Donkey anti rat IgG Abcam, Cambridge ab150153 1: 500 (IF) 
Goat anti rabbit IgG Dako, Glostrup E0432 1: 200 (IHC) 
Goat anti rabbit IgG-HRP GeneTex, San Antonio GTX213110-01 1: 5000 (WB) 
Sheep anti Dig-AP Roche, Mannheim 11093274910 1: 500 (ISH) 
 
8.5 Equipments 
Benchtop Centrifuge (Universal 320) Hettich, Germany 
Biological Safety Cabinet (MSC-Advantage) Thermo, Germany 
Cell culture CO2 incubator (Heracell150i ) Thermo, Germany 
Eppendorf BioPhotometer plus Eppendorf, Germany 
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Eppendorf Thermo Mixer Eppendorf, Germany 
FUSION-FX7 advanced Vilber Lourmat, Germany 
Gel documentation system (BioDocAnalyze) Biometra, Germany 
Heating block (LS 2) VLM, Germany 
Heidolph Reax 2000 shaker Heidolph, Germany 
HERAfreeze™ HFU T Series -86°C Freezer Thermo, Germany 
Incubating Mini Shaker VWR, Germany 
Invitrogen Power Ease® 500 Power Supply  Thermo, Germany 
Leica ICC50 HD microscope Leica, Germany 
Magnetic Stirrer (BLSH0007) IKAMAG, Germany 
Mastercycler Eppendorf, Germany 
METTLER AE 240 balance Mettler, Germany 
Microbiological incubator (SERIES 6000) Heraeus, Germany 
Microlitre Centrifuge (MIKRO 220R) Hettich, Germany 
Microwave oven LG, South Korea 
Milli-Q® Direct Water Purification System Merck KGaA, Germany 
Mini-PROTEAN Tetra Cell Bio-Rad, Germany 
NanoDrop ND-1000 PEQLAB, Germany 
pH meter (S20K)  Mettler-Toledo, Switzerland 
Phase-contrast inverted microscope (CK2) Olympus, Germany 
Power PAC 200 Bio-Rad, Germany 
PyroMark Q24 Cartridge Qiagen, Germany 
Pyromark Q24 instrument Qiagen, Germany 
Rotor-Gene Q PCR cycler Qiagen, Germany 
Standard Mini-Centrifuge Fisherbrand, Germany 
T100TM Thermal Cycler  Bio-Rad, Germany 
Trans-Blot SD Semi-Dry Transfer Cell Bio-Rad, Germany 
Ultra Turrax  IKA, Germany 
Water bath (JB Aqua 5plus) Grant, Germany 
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8.6 TET1–3, DNMT1 and DNMT3A mRNA levels in donor swim-up and 
non-swim-up sperm samples 
In order to confirm that the non-swim-up sperm samples from the healthy 
donors (TET1, n = 58; TET2–3, n = 63; DNMT1 and DNMT3A, n = 36) were 
also suitable for this study, we performed the following experiment: freshly 
isolated RNA from swim-up sperm cells of 12 healthy donors were analyzed 
for TET1–3, DNMT1 and DNMT3A mRNAs by RT-qPCR. The results showed 
that no differences of TET1 (1.28 ± 0.16 (± 0.57) versus 1.49 ± 0.28 (± 2.15); 
mean ± SEM (± SD), P > 0.05), TET2 (0.95 ± 0.15 (± 0.54) versus 0.90 ± 0.11 
(± 0.84), P > 0.05), TET3 (1.63 ± 0.32 (± 1.11) versus 1.67 ± 0.21 (± 1.63), 
P > 0.05), DNMT1 (1.19 ± 0.17 (± 0.59) versus 1.59 ± 0.17 ( ± 1.04), P > 0.05) 
and DNMT3A (2.01 ± 0.48 (± 1.66) versus 2.36 ± 0.17 (± 1.03), P > 0.05) 
mRNA levels were found between the swim-up samples and the non-swim-up 
samples (Table 7). Therefore, we conclude that the non-swim-up sperm 
samples were also suitable for this study. 
Table 7 TET1–3, DNMTA and DNMT3A mRNA levels in swim-up and non- 
swim-up sperm samples from healthy donors determined by RT-qPCR 
Gene     Swim-up                 Non-swim-up          P-value 
TET1     1.28 ± 0.16 (± 0.57), n = 12   1.49 ± 0.28 (± 2.15), n = 58   P = 0.24 > 0.05 
 TET2     0.95 ± 0.15 (± 0.54), n = 12   0.90 ± 0.11 (± 0.84), n = 63   P = 0.36 > 0.05 
 TET3     1.63 ± 0.32 (± 1.11), n = 12   1.67 ± 0.21 (± 1.63), n = 63   P = 0.57 > 0.05 
 DNMT1   1.19 ± 0.17 (± 0.59), n = 12   1.59 ± 0.17 (± 1.04), n = 36   P = 0.29 > 0.05 
 DNMT3A  2.01 ± 0.48 (± 1.66), n = 12   2.36 ± 0.17 (± 1.03), n = 36  P = 0.20 > 0.05 
Relative mean values ± SEM (± SD), P-values of Mann-Whitney U-test and number of 
analyzed samples are given. 
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9. ABBREVIATIONS 
5caC 5-carboxycytosine 
5fC 5-formylcytosine 
5hmC 5-hydroxymethylcytosine 
5hmU 5-hydroxymethyluracil 
5mC 5-methylcytosine; 
A Asthenozoospermia 
AID Activation-induced deaminase 
AM Active modification 
APS Ammonium persulfate 
ART Assisted reproductive technology 
BCA Bicinchoninic acid 
BER Base-excision repair 
bp base pair 
BSA Bovine serum albumin 
oC Degree Celsius 
C Cytosine 
cDNA Complementary DNA 
CIS Carcinoma-in situ 
COBRA Combined bisulfite restriction analysis 
cRNA Complementary RNA 
Cys-rich Cysteine-rich region 
DAB 3,3’-Diaminobenzidine 
DAPI 4′,6-diamidino-2-phenylindole 
DEPC Diethypyrocarbonate 
DIG Digoxygenin 
DMRs Differentially methylated regions 
DNA Desoxyribonucleic acid 
DNase Desoxyribonuclease 
DNMT DNA methyltransferase 
dNTP 2’-deoxynucleoside-5’-triphosphate 
DSBH Double-stranded β-helix 
DTT Dithiothreitol 
EDTA Ethylene diamine tetraacetic acid 
ESC Embryonic stem cells 
F Forward primer 
FR Fertilization rate 
g gram 
GAPDH Glyceraldehyde 3-phosphate dehydrogenase 
GCCs Germ cell cancer tissues 
h hour 
HE Hematoxylin-eosin 
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ICC Immunocytochemistry 
ICSI Intracytoplasmic sperm injection 
IF Immunofluorescence 
IHC Immunohistochemistry 
ISH In-situ hybridization 
kDa kilo Dalton 
LB Lysogeny Broth 
M.SssI CpG methyltransferase 
MEF Mouse embryonic fibroblasts 
mg milligram 
min minute 
Mil Million 
ml milliliter 
mM millimolar 
NTTs Normal testicular tissues 
NZS Normozoospermia 
O Oligozoospermia 
PBS Phosphate buffered saline 
PD Passive dilution 
PFA Paraformaldehyde 
PGCs Primordial germ cells 
PM Primary magnification 
PVDF Polyvinylidene difluoride 
qPCR quantitative PCR 
R Reverse primer; 
RNA Ribonucleic acid 
RNase Ribonuclease 
ROC Receiver operating characteristic 
rpm revolutions per minute 
RT-PCR Reverse transcription-polymerase chain reaction 
RT-qPCR Quantitative reverse transcription PCR 
RT Room temperature 
SB Scale bars 
SD Standard deviation 
SDS Sodium dodecyl sulfate 
sec second 
SEM Standard error of mean 
TDG Thymine DNA glycosylase 
TEMED Tetramethylethylenediamine 
TET Ten eleven translocation 
Tm Primer melting temperature; 
WB Western-blot analysis 
µg microgram 
µl microliter 
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